LT3113B - Novel phospholipide derivatives - Google Patents
Novel phospholipide derivatives Download PDFInfo
- Publication number
- LT3113B LT3113B LTIP620A LTIP620A LT3113B LT 3113 B LT3113 B LT 3113B LT IP620 A LTIP620 A LT IP620A LT IP620 A LTIP620 A LT IP620A LT 3113 B LT3113 B LT 3113B
- Authority
- LT
- Lithuania
- Prior art keywords
- compounds
- phosphate
- pharmaceutical composition
- composition according
- mmol
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 229910019142 PO4 Inorganic materials 0.000 claims description 30
- 239000010452 phosphate Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 28
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 22
- 239000002904 solvent Substances 0.000 claims description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 14
- 150000002500 ions Chemical class 0.000 claims description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 229910052698 phosphorus Inorganic materials 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 230000002378 acidificating effect Effects 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002168 alkylating agent Substances 0.000 claims description 2
- 229940100198 alkylating agent Drugs 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 210000001185 bone marrow Anatomy 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 208000004554 Leishmaniasis Diseases 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000000824 cytostatic agent Substances 0.000 claims 1
- 230000001085 cytostatic effect Effects 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 239000012046 mixed solvent Substances 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 125000004437 phosphorous atom Chemical group 0.000 claims 1
- 208000017520 skin disease Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 117
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 61
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 54
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 49
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 44
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- 229910021529 ammonia Inorganic materials 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 26
- 239000010410 layer Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
- -1 acyclic ethers Chemical class 0.000 description 16
- 239000002585 base Substances 0.000 description 16
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 14
- 239000001632 sodium acetate Substances 0.000 description 14
- 229960004249 sodium acetate Drugs 0.000 description 14
- 235000017281 sodium acetate Nutrition 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 229920001429 chelating resin Polymers 0.000 description 8
- 238000000921 elemental analysis Methods 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000011574 phosphorus Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 239000003480 eluent Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 150000008282 halocarbons Chemical class 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000004292 cyclic ethers Chemical class 0.000 description 3
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229930195734 saturated hydrocarbon Natural products 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- BTANRVKWQNVYAZ-SCSAIBSYSA-N (2R)-butan-2-ol Chemical compound CC[C@@H](C)O BTANRVKWQNVYAZ-SCSAIBSYSA-N 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 2
- 238000003818 flash chromatography Methods 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
- TVIVIMTXHOLYOB-UHFFFAOYSA-N (1-methylpiperidin-1-ium-4-yl) octadecyl phosphate Chemical compound CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[NH+](C)CC1 TVIVIMTXHOLYOB-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- BAUWRHPMUVYFOD-UHFFFAOYSA-N 1-methylpiperidin-4-ol Chemical compound CN1CCC(O)CC1 BAUWRHPMUVYFOD-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 102000006835 Lamins Human genes 0.000 description 1
- 108010047294 Lamins Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000218225 Trema Species 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940095054 ammoniac Drugs 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- SDIXRDNYIMOKSG-UHFFFAOYSA-L disodium methyl arsenate Chemical compound [Na+].[Na+].C[As]([O-])([O-])=O SDIXRDNYIMOKSG-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000005053 lamin Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
- GBIXPTZKRXWEDI-UHFFFAOYSA-N methyl hydrogen sulfate;toluene Chemical compound COS(O)(=O)=O.CC1=CC=CC=C1 GBIXPTZKRXWEDI-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003248 quinolines Chemical group 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229940082707 skyla Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
- C07F9/106—Adducts, complexes, salts of phosphatides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Abstract
Description
Išradimas priskiriamas naujiems pasižymintiems priešnavikiniu fosfolipidų dariniams, ir priešgrybeliniu aktyvumu, jų komp o zicijoms, ir panaudoj imui.The invention relates to novel novel antitumor phospholipid derivatives, and to antifungal activity, their compositions and uses.
gavimo ir .valymo būdui, farmacinėms į kurias įeina šie junginiai, jų gamybaifor the preparation and purification of pharmaceutical compositions containing these compounds
Iš paraiškos Europos patentui 108565 žinoma, kad junginiai, 'kurių bendra formulė:It is known from the European patent application 108565 that compounds of the general formula:
Rr (0) n~P-OCH2CH2N**R3,R r (0) n ~ P-OCH 2 CH 2 N ** R 3 ,
ir jų farmaciškai tinkamos druskos, kur Rj yra alifatinio angliavandenilio iš 8-30 C-atomųliekana: R2, R3 ir R4 yra vienodi- arba skirtingi ir yra vandenilis arba žemesniojo alkilo liekanos, arba NR2R3R4 yra ciklinė amonio grupė: n yra 0 arba 1, pasižymi priešnavikiniu aktyvumu ir priešgrybeliniu poveikiu.and pharmaceutically acceptable salts thereof, wherein R 1 is an aliphatic hydrocarbon residue having from 8 to 30 C atoms: R 2 , R 3 and R 4 are the same or different and are hydrogen or lower alkyl or NR 2 R 3 R 4 is cyclic ammonium; group: n is 0 or 1, exhibits antitumor activity and antifungal activity.
Šis išradimas apima alkil- -arba alkenfosfatus, kurių o cholino liekanoje yra heterociklinis žiedas, šios 25 junginių klasės gavimo būdą, o taip pat ir,~ farmacinę kompoziciją, bei šios farmacinės kompozicijos, į kurią įeina minėti junginiai kaip veiklioji medžiaga, pagaminimo būdą.The present invention includes a process for the preparation of this class of compounds, as well as a pharmaceutical composition, and alkyl-or alkenophosphates having a heterocyclic ring in the choline moiety, and a process for the preparation of said pharmaceutical composition comprising said compounds as active ingredient.
Junginiai pagal šį išradimą netikėtai parodė geresnį priešnavikinį aktyvumą, negu EP-A 108565 aprašyti atviros grandinės junginiai.The compounds of the present invention unexpectedly exhibit better antitumor activity than the open-chain compounds described in EP-A 108565.
Išradimas apima ir naujų junginių gavimo ir valymo 35 būdus. Pirmoji šių junginių gavimo stadija yra fosforo oksichlorido reakcija su ilgos grandinės alkoholiais, vykdoma halogenus turinčiuose arba aromatiniuose angliavandeniliuose, sočiuose cikliniuose arba acikilniuose eteriuose.The invention also encompasses processes for the preparation and purification of novel compounds. The first step in the preparation of these compounds is the reaction of phosphorus oxychloride with long chain alcohols in halogenated or aromatic hydrocarbons, saturated cyclic or acyclic ethers.
Pirmoji gavimo būdų? A stadija yra fosforo oksichlorido 5 - reakcija su ilgos grandinės alkoholiais, vykdoma halogenus turinčiuose angliavandeniliuose,. sočiuose cikliniuoseeteriuose, acikliniuose eteriuose, sočiuose angliavandeniliuose, turinčiuose nuo 5 iki 10 anglies atomų, skystuose aromatiniuose angliavandeniliuose, taip pat ir halogenus (ypač chlorą) turinčiuose aromatiniuose angliavandeniliuose, arba aukščiau minėtų tirpiklių mišiniuose, tam tikrais atvejais esant įprastoms bazėms.First ways of receiving? Step A is the reaction of phosphorus oxychloride 5 with long chain alcohols on halogenated hydrocarbons. saturated cyclic ethers, acyclic ethers, saturated hydrocarbons having from 5 to 10 carbon atoms, liquid aromatic hydrocarbons, including aromatic hydrocarbons containing halogens (particularly chlorine), or mixtures of the above solvents, where appropriate in the presence of conventional bases.
Kaip. halogėnus .'turintys angliavandeniliai , tinka • i.How. halogens .'t containing hydrocarbons, suitable for • i.
- angliavandeniliai, kuriuose yra nuo 1 iki 6 anglies atomų ir kuriuose vienas arba daugiau., arba visi vandeniliai yra pakeisti chloro atomais. Pavyzdžiui, gali būti naudojami metileno chloridas, chloroformas, etileno chloridas, chorbenZolas, dichlorbenzolas. -.iš halogenus turinčių aromatinių angliavandenilių daugiausia naudojami vieną arba du halogenus turintys angliavandeniliai.- hydrocarbons having from 1 to 6 carbon atoms and one or more of which are replaced by chlorine atoms. For example, methylene chloride, chloroform, ethylene chloride, chorobenzene, dichlorobenzene can be used. Of the halogenated aromatic hydrocarbons, the predominantly used is one or two halogenated hydrocarbons.
Kaip sotūs cikliniai eteriai gali būti' naudojami 5arba 6-nariai eteriai, susidedantys iš anglies atomų ir vieno arba dviejų deguonies atomų. Tokie eteriai yra, pavyzdžiui, tetrahidrofuranas, dioksanas.5 or 6-membered ethers consisting of carbon atoms and one or two oxygen atoms may be used as saturated cyclic ethers. Such ethers are, for example, tetrahydrofuran, dioxane.
Kaip acikliniai eteriai gali būti skysti eteriai su 2-8 anglies atomais, pavyzdžiui, diėtilo eteris, diizobųtįlo eteris, metilo tret. - butilo eteris, diizopropilo eteris.Acyclic ethers can be liquid ethers with 2-8 carbon atoms, such as diethyl ether, diisobutyl ether, methyl tert. - butyl ether, diisopropyl ether.
Kaip sotūs angliavandeniliai tinka skysti linijinės arba šakotos grandinės angliavandeniliai, turintys nuo 3 iki 10 anglies atomų, pavyzdžiui, pentanas, heptanas, cikloheksanas.Suitable saturated hydrocarbons are liquid straight or branched chain hydrocarbons having from 3 to 10 carbon atoms, such as pentane, heptane, cyclohexane.
heksanas,hexane,
Kaip aromatiniai angliavandeniliai tinka, pavyzdžiui, benzolas ir alkil-benzolai, kurių alkilo pakaitas turi nuo 1 iki 5 anglies atomų.Suitable aromatic hydrocarbons are, for example, benzene and alkylbenzenes having from 1 to 5 carbon atoms in the alkyl substituent.
Kaip bazės, tiek fosforo oksichlorido reakcijoje su ilgos grandinės alkoholiais, tiek ir fosforo rūgšties diesterio gavimui tinka aminai, pavyzdžiui, alifatiniai aminai, kurių formulė NR1R2R3, kurioje Rx, R2 ir R3 yra vienodi arba skįrtingi ir yra vandenilis aria alkilas, turintis 1-6 anglies atomus, o taip pat ir aromatiniai laminai, tokie kaip piridinas, pikolinas, chinolinas.As bases, amines such as aliphatic amines of formula NR 1 R 2 R 3 in which R x , R 2 and R 3 are the same or different and are suitable for the reaction of phosphorus oxychloride with long chain alcohols and the preparation of phosphoric acid diester hydrogen aria alkyl having from 1 to 6 carbon atoms, as well as aromatic lamins such as pyridine, picoline, quinoline.
Fosforo rūgšties diesteriui gauti reikalingos bazės gali būti pridedamos tuo pačiu metu arba prieš pridedant aminoalkoholį arba amonioalkoholio druską. ///='.The bases required to obtain the phosphoric acid diester may be added at the same time or prior to the addition of the amino alcohol or the ammonium salt. /// = '.
* .Šioms · reakcijoms atlikti visais atvejais yra reikalingas tirpiklis, t.y. jeigu pirmoji reakcijos stadija ir galėtų būti atliekama be kokio nors ypatingo ° tirpiklio, jo vistiek reikia pridėti.* .This reaction requires in all cases a solvent, i.e. if the first step of the reaction can be carried out without any particular solvent, it must still be added.
' ‘t* ' .'' T * '.
Fosforo oksichlorido molinis santykis su ilgos grandinės alkoholiu turi būtį, pavyzdžiui, tarp 1,5:1= ir‘ 0,8:1.The molar ratio of phosphorus oxychloride to long chain alcohol should be, for example, between 1.5: 1 = and '0.8: 1.
Į reakelją yra pridedamas ąinindalkdholid arba '''7 'em©ni©alk©b©lĮ©'''4rųskės perteklius, palyginus §ų ilgos grandinės alkoholi©. kiekiu (perteklius, skaičiuojant/ moliais, yra'apie 1,1-1,5). < ' 'To the reagent is added an excess of dihydroxide or '' '7' em © ni © alk © '' '4' compared to § long chain alcohol. in quantities (the excess in moles / mole is about 1.1-1.5). <''
Jeigu fosforo oksichlorido reakcija su ilgos grandinės alkoholiu vykdoma esant bazei, šios bazės kiekis yra ' nuo 1 iki 3 molių, o POC13 yra 1 molis. Gaminant fosforo rūgšties diesterį, naudojamos bazės kiekis yra nuo 1 iki 5 molių, skaičiuojant 1 moliui medžiagos.When the reaction of phosphorus oxychloride with a long chain alcohol is carried out in the presence of a base, the amount of this base is from 1 to 3 moles and POCl 3 is 1 mole. The amount of base used in the preparation of the phosphoric acid diester is 1 to 5 moles per mole of material.
1.13113 B ' 41.13113 B '4
Fosforo oksichlorido reakcija su ilgos grandinės alkoholiais atliekama^ esant -30 - +30°C temperatūrai, dažniausia -15 - +5°C, ypatingai tarp -1.0°C ir -5°C.The reaction of phosphorus oxychloride with long chain alcohols is carried out at a temperature of -30 to + 30 ° C, usually -15 to + 5 ° C, in particular -1.0 ° C to -5 ° C.
o e · Si reakcija vykdoma 0,5-5 vaidažniausiai 1-3 vai., ypatingai 1,5-2 vai.. Jei reakcija vykdoma esant bazei, ji paprastai būna greita (apie 30 ain.).o e · This reaction is carried out for 0.5 to 5 hours at most for 1 to 3 hours, especially for 1.5 to 2 hours. If the reaction is carried out in the presence of a base, it is usually rapid (about 30 years).
Po to pridedamas aiainoalkohoĮis arba amoni o alkoholio druska dalimis arba iš karto. ' .j__-r—Subsequently, the basic alcohol or the ammonium alcohol salt is added in portions or immediately. '.j __- r—
Kaip amonioaikoholių druskos* yra tinkamos amonioalkoholių mineralinių rūgščių ftokių, kaip pvz., sieros rūgšties, druskos •rūgšties) druskos, arba kitokiosAmmonium alcohol alcohols * are suitable salts of mineral acids of ammonium alcohols, such as sulfuric acid, hydrochloric acid, or other salts.
15.. organinių rūgščių (pvz., facto, p-toluolsulf©rūgšties) ir panašios druskos.15 .. organic acids (eg., F is acetic acid, p-toluolsulf © acid), and similar salts.
: Ši reakcijos stadija : vykdoma inertiniame tirpiklyje. Tinkami yra tie patys tirpikliai, kaip ir fosforo oksichlorido sąveikos su ilgos grandinės alkoholiais: This reaction step : is carried out in an inert solvent. The same solvents as the interaction of the phosphorus oxychloride with the long chain alcohols are suitable
Dažniausiai .naudojami bazių tirpinimui tirpikliai yra:The most commonly used solvents for base dissolving are:
halogenus turintys angliavandeniliai, sotūs cikliniai eteriai/ sotūs angliavandeniliai su 5-10 anglies atomų, skysti aromatiniai angliavandeniliai arba minėtų tirpiklių/ mišiniai. Čia turima galvoje tie patys -tirpikliai, kurie gali būti naudojami fosforo oksichlorido sąveikos su ilgos grandinės alkoholiais reakcijoje.halogenated hydrocarbons, saturated cyclic ethers / saturated hydrocarbons having from 5 to 10 carbon atoms, liquid aromatic hydrocarbons or mixtures thereof. This means the same solvents which may be used in the reaction of phosphorus oxychloride with long chain alcohols.
Pridėjus bazės, reakcijos mišinio temperatūra pakyla. Reikia stengtis, kad temperatūra būtų išlaikoma tarp 0°C ir 40°C, - geriausia 10-30°C, ypatingai 15~20°C.With the addition of base, the temperature of the reaction mixture rises. Care should be taken to maintain the temperature between 0 ° C and 40 ° C, preferably 10-30 ° C, especially 15 ~ 20 ° C.
Po to, reakcijos mišinys maišomas 5-30°C temperatūroje, geriausia 15-25°C temperatūroje (pavyzdžiui, nuo 1 iki 40 valandų, geriausia 3-15 valandų),The reaction mixture is then stirred at 5-30 ° C, preferably 15-25 ° C (for example, 1 to 40 hours, preferably 3-15 hours),
Gautas reakcijos produktas hidrolizuojamas, pridedant vandens. Hidrolizė turi būti atliekama 10-30°C temperatūroje, geriausia 15-30°C, ypač 15-20°C temperatūroje. Hidrolizei naudojamame tirpale gali būti pridėta bazinių medžiagų. Tokios bazinės medžiagos gali būti šarminių ir žemės šarminių metalų karbonatai- arba hidrokarbonatai. Kad pilnai įvyktų hidrolizė, reikia maišyti dar 0,5-4 vai., geriausia 1-3 vai., ypač 1,52,5 vai. 10-30cC temperatūroje, geriausia 15-25°C, ypač 18-22°C temperatūroje. ' . - ‘The resulting reaction product is hydrolyzed by addition of water. The hydrolysis should be carried out at 10-30 ° C, preferably at 15-30 ° C, especially at 15-20 ° C. Basic substances may be added to the solution used for hydrolysis. Such base materials may be alkali and alkaline earth metal carbonates or hydrocarbons. A further 0.5-4 hours, preferably 1-3 hours, especially 1.52.5 hours, are needed for complete hydrolysis. C 10-30 C, preferably 15-25 ° C, especially 18-22 ° C. '. - '
Po to, reakcijos mišinys plaunamas vandens ir alkoholio (geriausiai aiifatinio sotaus alkoholio, turinčio 1-4 anglies atomus) mišiniu, kuriame gali būti ir bazinė medžiaga. Vandens:alkoholio santykis mišinyje, pavyzdžiui, - gali būti tarp 5 ir 0,5, geriausia 1-3 (pagal tūrį). Kaip bazinė medžiagą tokiame perplovimo mišinyje gali būti panaudoti, pvz., šarminių ir žemės šarminių metalų karbonatai ir hidrokarbonatai, bei amoniakas (pvzvandeninis amoniako tirpalas). Ypatingai tinka 3% natrio karbonato tirpalas vandenyje.The reaction mixture is then washed with a mixture of water and alcohol (preferably aliphatic saturated alcohol having 1 to 4 carbon atoms), which may also contain a base. The ratio of water: alcohol in the mixture, for example, may be between 5 and 0.5, preferably 1-3 (by volume). As a base material, such alkaline and earth alkaline carbonates and hydrocarbonates as well as ammonia (such as aqueous ammonia solution) may be used as the base material in such a wash. A 3% solution of sodium carbonate in water is particularly suitable.
7 ’ . . '7 '. . '
Reikalui esant, reakcijos mišinys gali būti plaunamas rūgščiu tirpalu.If necessary, the reaction mixture may be washed with an acidic solution.
Perplovimas . rūgščiu tirpalu yra reikalingas nesureagavusios bazės.pašalinimui iš reakcijos mišinio, ypač jeigu tirpikliu’buvo naudotas metileno chloridas. Perplovimo tirpalas susideda iš vandens ir alkoholio.Flushing. acid solution is required to remove the unreacted base from the reaction mixture, especially if methylene chloride was used as the solvent. The wash solution consists of water and alcohol.
- Geriausiai tinka mišiniai, kuriuose yra alifatinis alkoholis# turintis 1-4 anglies atomus7 Mišinyje gali būti ir rūgštis. Vandens/alkoholio santykis šiame . mišinyje/- gali.: būti, pavyzdžiui, tarp 5 ir 0,5, geriausia .1-37. (pagal tūrį)' . Rūgštys šiame parpi o vimo mišinyje- gali : būti .mineralinės arba organinės,' pvz., -draskos,- sieros, vyno' arba citrinos, ypatingai .tinka 1®%- draskos' -rūesštiestimalas vandenvie.^ . · <- Mixtures containing an aliphatic alcohol containing 1-4 carbon atoms are preferred7 The acid may also be present. The water / alcohol ratio in this. in the mixture / - may: be, for example, between 5 and 0.5, preferably .1-37. (by volume) '. The acids in this blend may be: mineral or organic, such as -draze, sulfur, wine 'or lemon, especially suitable for 1®% -dryage' -the most acidic water. · <
1G /Po to/ ,7 dar -kartą- plaunama/ vandens ir alkoholio mišiniui^ Geriausiai . / tinka - mišiniai, .7 kuriuose . yra ąlifatinis /alkoholis# turintis 1-4. anglies atomus;. Šiam;/:./mišinyjė/ .'/gali·. / , būti/ / ir / bazinė/: '.medžiaga.,1G / After /, 7 more - once - for / water / alcohol mixture ^ Best. / suitable - mixtures, .7 in which. is an aliphatic / alcohol # containing 1-4. carbon atoms; For this; /: ./ mixer /. '/ Can ·. /, be / / and / base /: '.material.,
VaėdeBė.rąikohelio santykis šiame, mišinyje gali būti, : pavyzdžiui., tarp -'5- i r 0, 5, .geriausia 1 -3 .The ratio of the ratios to the ratio in this mixture may be, for example : between -'5- and 0, 5, preferably 1 -3.
‘ ' Išplauto-'-reakcijos- mišinio> .porcijos supilamos kartu -ir džiovinama^įprastu būdu.. Po to /tirpiklis /nūgarinamas / (geriausia vakuume 7 pvz*, nuo . 5 - - iki -; /100 mbarų), pridėjus 150-10OS ml, geriausia: 300—lOO ^&l, y^ 450550 ml alifatinio-',alkoholio <uurodytas.:'-aikoholio 'kiekis '7/ skaičiuojamas 1 moliui džiovinamo/ produkto). Šiam : t ikslui . geriausiai tinka ./'sotus...-'alifatiniai alkoholiai·.,, kurių, grandinę · sudaro;/1--5/abglihs/atomai. -Ypač tinka n25 butanolis, / izopropanolis. / Šis / alkoholio pridėjimas reikalingas tam,.kad būtų visiškai pašalintas vanduo· ir nesusidarytų putos.The portions of the washed -'-reaction-mixture> are combined together -and dried ^ in the usual manner. Then / solvent / evaporated / (preferably in vacuum 7 eg * from 5 - to -; / 100 mbar) plus 150-10OS ml, preferably: 300 - 100 ^ & l, y - 450550 ml aliphatic - ', alcohol <.:: -' - alcohol 'content' 7 / (based on 1 mole dried / product). For this goal . best suited to ./'sotus...-'aliphatic alcohols ·., whose, chain · consists of; / 1--5 / abglihs / atoms. -N25 butanol / isopropanol is particularly suitable. / This / addition of alcohol is required to completely remove water · and foam.
Toliau ' produktas gali būti ;valomas-7taip: nevalytas produktas tirpinamas karštame etanolyje, nufiltruojamos neištirpusios liekanos ir apdirbamas mišraus tipo jonitais, pvz., amberlifcu MB 3 etanolio tirpale. Vietoj mišraus tipe/ jonitų gali būti panaudoti ir kiti pramoniniu būdu gaminami rūgštiniai arba baziniai jonitai, kurie gali būti sumaišomi:, arba iš pradžių panaudojamas vienas, o po to kitas.Further, the product may be purified as follows: The crude product is dissolved in hot ethanol, the insoluble residue is filtered off and treated with mixed-type ion exchangers such as amberlift in MB 3 ethanol solution. Other commercially available acidic or basic ion exchangers may be used in place of the mixed type / ion exchanger, or may be mixed first, followed by one.
Medžiaga iškristalinama iŠ tirpalo» pridėjus ketonų, pvz. .acetono arba metiletilketono, o kai kuriais ' atvejais pakanką įpilti aukščiau minėtų tirpiklių.The material is crystallized from solution »with the addition of ketones, e.g. .acetone or methylethylketone, and in some cases, the above solvents are sufficient.
>>
Kartaiscgali būti tikslinga produkto valymui panaudoti 5 kolonėlių chromatografiją arba ekspres^chromatografiją per silikagelį. Eliuentu gali būtu, pavyzdžiui, mišinys iš chloroformo, metileno chlorido, me’tanolio ir 25% amoniako tirpalo. C Sometimes it may be appropriate to use the product to clean five column chromatography or express ^ by silica gel chromatography. The eluent may be, for example, a mixture of chloroform, methylene chloride, methanol and 25% ammonia.
Gavimo būdas B yra tolimesnis produktų, gautų pagal būdą A, prijungiant aminoalkoholį, alkilinimas. Alkilinimo /agentais gali būti panaudoti, pavyzdžiui, toluolsulforūgštiės metilo esteris arba dimetilsulfatas. Tirpikliais galibūti aukščiau minėti tirpikliai.Method B is a further alkylation of the products obtained by Method A by coupling an amino alcohol. Alkylating agents may be used, for example, toluene sulfuric acid methyl ester or dimethyl sulfate. Solvents may be those mentioned above.
Kaip bazinės medžiagos gali būti panaudoti, pavyzdžiui, šarminių metalų karbonatai. Reakcija vykdoma aukštesnėje+ /+ temperatūroje,pvz., tirpiklio virimoAs base materials, for example, alkali metal carbonates can be used. The reaction is carried out at elevated + / + temperatures, e.g., boiling the solvent
- / -temperatūroje.'' / .:+ + +/. '- / -temperature. '' / .: ++ ++ /. '
20... Pavyzdžiai ' . ž / +1 pavyzdys ' ų . Pavadinimas (IOPAC nomenklatūra):20 ... Examples'. z / +1 example. Name (IOPAC nomenclature):
,\;-7 . 7 J + + <»({(oktadeciloksi)hiaroksifosfenil)oksi)-i,1-dimetilpipęridinio hidroksido vidinė druska, \; - 7. 7 J + + <(({(octadecyloxy) hyroxyphosphenyl) oxy) -i, 1-dimethylpiperidine hydroxide inner salt
Sutrumpintas, pavadinimas: 7 · ' 7 ' · +Abbreviated, Name: 7 · '7' · +
Oktadecil-(1r1-dimetilpipęridinio-4-il)fosfatasOktadecil- (1 r 1-dimethylpiperidinium-4-yl) phosphate
C25H52SO4P (461, 66) .1/2 H2OC 25 H5 2 SO 4 P (461, 66) .1 / 2 H 2 O
Gavimo būdas A:Method A:
LT3113.B • - 8 lflk,3 ml <0,117. mol) fosforo afcsiehlorido įdedama į ί&ΘLT3113.B • - 8 lflk, 3 ml <0.117. mol) of phosphorus afcsiehloride is added to ί & Θ
..'/'/' ®Γ ehloroformo ir atšaldoma/iki 5-10aC7. Per 30 min... '/' / '®Γ ehloroform and cooled / to 5-10 a C7. Within 30 minutes
' -'aaBišant.· ..sulašinama. -.27,0'· g <0,10 mol) 1-oktadekanolio, ’ ištirpinto 100/ ml . chloroformo ir 35 ml piridino.'-'aaBishant. · ..dripping. -.27.0 '· g <0.10 mol) 1-octadecanol dissolved in 100 / ml. of chloroform and 35 ml of pyridine.
· ' Kaišoma dar .30 tein.. 5t-1Ū°C temperatūro je ir pridedama· 'Plug in for another .30 degrees. 5t-1ºC and add
3-S, i - g <70*1,3 sol) ‘ 4“hidroksi-i,l-dimetilpiperidinio3-S, i - g <70 * 1.3 sol) '4' hydroxy-1,1-dimethylpiperidine
- - .. /; terilafcOi. Pridėjus, dar/-40 ;/7ϊ^ί.·.·,piridino:-: ir. 30 ml 'DMF, maišoma -.../kambario/·- 7tespėratūroje.. 24 ·< valandas, Po to < hidrolimojama- iS-.-ml//vandens,'/maišant./dar 30 minučių.- - .. /; terilafcOi. Adding, else / -40 ; /7ϊ^ί.·.·,pyridine:-: and. 30 ml 'DMF, stirred at -.../ room / · - 7t.specification .. 24 · <hours, then <hydrolyzed- iS -.- ml // water,' / with stirring / for another 30 minutes.
10'- / Qrganinis',..,:,s'iuoksnis- -plaunamas//vandens/metanolio (Iii),10'- / Organic ', ..,:, Layer-washable // water / methanol (III),
- .3%·'· Hs^CSj/metaiialio^/^Clii) ir vėl vandens/metanolio . (1:1) . Bi-šiniais.· ....<po /7200/ ml), ; Srgani^--/:.farė.' ..nugarinama, '- .3% · '· Hs ^ CSj / yrialio ^ / ^ Clii) and again water / methanol. (1: 1). Biol. · .... <po / 7200 / ml) , ; Srgani ^ - / : .fare. ' ..inhibiting, '
- -liekana -tirpinama.:-.300./;ml.<.kaisto-/'etanolio,-./atšaldoma ir ' filtruoj/ama,. . .Fil/fcratas'/,:mąįšomas· su 80 . g jonito ~ / afcerlito ffi '3' — nuf iltruo jamaš-. jonitas ir/ nugarinamas tirpiklis, 'liekana../7 aferistaiinamaįš 301 si metiletilketono, --nuspaudžiama, /ir/./džiovinama,- vakuume virš ' IW. - ' 20 - Išeiga:· 4,71 7g f 10%),.·- -the residue -dissolved.:-.300./ml.<.hand-/'ethanol ,-./cooled and 'filtered'. . .Fil / fcratas' /,: · stir with '80. g jonito ~ / afcerlito ffi '3' - nuf iltruo jamaš-. ion exchange and / or solvent evaporation, 'residue ../7 afferent is converted to 301 siylethylethylketone, - pressed, / / / / dried, - under vacuum over' IW. - '20 - Yield: · 4.71 7g f 10%),. ·
Plonasluoksnė',. eferomatogramar? Thin layer ',. eferomatogramar ?
7-: (Cfeloroformas/m.et.anolis/1·./H . natrio '.acetatas7- : (Ciforoform / m.et.anol / 1. / H. Sodium 'acetate
25%. amoniake 70:40:10)25%. ammonia 70:40:10)
EU - 0 ,17 (l-butanolis/acto rūgštis/vanduo 40:10:10) 'EU - 0, 17 (l-butanol / acetic acid / water 40:10:10) '
Lyd, temp: 270-271°C Įskyla).Melting point: 270-271 ° C (dec.).
Gavimo būdas B:Method B:
''
20,1 ml (0,22 mol)' fosforo oksichlorido įdedama į lOCml * ' ' 0 metiieno chlorido, atšaldoma iki 5-10 C temperatūros n 30 min. laikotarpyje maišant pridedama 54,1 g (0,20 mol) oktadekanolio tirpalas 400 ml metiieno chlorido irAdd 20.1 ml (0.22 mol) of 'phosphorus oxychloride in 10 ml of methylene chloride, cool to 5-10 ° C for about 30 minutes. a solution of 54.1 g (0.20 mol) octadecanol in 400 ml of methylene chloride is added under stirring and
7.0,5 ml piridino. Maišoma dar vieną valandą ir po to lašinamas 29,9 g (0,26 mol) 4-hidroksi-l-metilpiperidino tirpalas 80 ml piridino. Maišoma 3 vai . J0°C temperatūroje, po to , šaldant ledu, hidrolizuojama 30 ml vandens, maišant dar vieną valandą. Organinis sluoksnis plaunamas vandens/metanolio (1:1), 3% druskos rūgštiės/metanolio (1:1) ir vandens/metanolio (Iii) mišiniais (po 200 ml). Organinė fazė džiovinsma Na2SO4, nugarinama iki nuosėdų, atsiradimo ir sumaišoma su 1 1 metiletilketono.Iš ' 1 1 metiletilketono, išsiskyrę .15 kristalai džiovinami vakuume virš P2O5.7.0.5 ml of pyridine. After stirring for another hour, a solution of 29.9 g (0.26 mol) of 4-hydroxy-1-methylpiperidine in 80 ml of pyridine is added dropwise. Stir in 3 or. At J0 ° C, 30 ml of water are then hydrolysed under ice-cooling with stirring for another hour. The organic layer was washed with water / methanol (1: 1), 3% hydrochloric acid / methanol (1: 1), and water / methanol (III) (200 mL each). The organic phase is dried over Na 2 SO 4 , evaporated to a precipitate, and mixed with 1 L of methylethylketone. From the 1 L of methylethylketone, the liberated .15 crystals are dried under vacuum over P 2 O 5 .
Išeiga: 54,1 g (60%) oktadęcil-(l-metįlpiperidino-4il) -f osf ato. /',' <Yield: 54.1 g (60%) of octadecyl- (1-methylpiperidin-4-yl) phosphate. / ',' <
98, 1 g (0,22 mol) oktadecil-(l-metilpiperidino-4-il) fosfato suspenduojama 500 ml’ absoliutaus etanolio ir pašildoma iki virimo. Virinant šu grįžtamu šaldytuvu dviejų: valandų bėgyje dedama pakaitomis padalintų į 8 porcijas iš viso .. 71,8 g (0,39 mol) p-toluol25 sulfbrūgštles metilo esterio įr 26,5 g (0,19 mol) kalio karbonato. / Pridėj minėtas /medžiagas, virinama dar vieną valandą šu grįžtamu -šaldytuvu. Atšaldoma, nufiltruojama, / filtratas nugarinamas iki pusės tūrio, ir tirpalas .sumaišomas su 150 g drėgno jonito (amberlito MB 3)Maišoma dvi valandas, po to tirpalas filtruojamas per adsorbento . Kieselgūro/aktyvuotos anglies sluoksnį. / Filtratas nugarinamas ir medžiaga , / iškristaiinama, pridėjus acetono. Kristalinė medžiaga /: perkristaiinama iš metiletilketono. 'ir džiovinama//// vakuume virš P2O5. ' ; ίο98.1 g (0.22 mol) of octadecyl (1-methylpiperidin-4-yl) phosphate are suspended in 500 ml of absolute ethanol and brought to boiling. During refluxing, add two portions of 8 hours in a total of 71.8 g (0.39 mol) of p-toluene sulfonic acid methyl ester and 26.5 g (0.19 mol) of potassium carbonate. / Add the above / materials and boil under reflux for another hour. Cool, filter, evaporate the filtrate to half volume and mix the solution with 150 g of wet ion (Amberlite MB 3). Stir for two hours, then filter through an adsorbent. Kieselguhr / activated carbon layer. / The filtrate is evaporated and the material / crystallized by the addition of acetone. Crystalline material /: recrystallized from methyl ethyl ketone. 'and dried // // in vacuo over P 2 O 5 . '; ίο
I šeiga s 46« 1 g ' (46%) oktadecil~ (1,. l..-tdimetilρiperidinio~ 4-i.l) fosfato* r, /7'I Seigo of 46 "1 g '(46%) octadecyl ~ (1 l ,. ~ ..- t dimetilρiperidinio 4-yl) phosphate * r / 7'
'5...'.· hydi temp-? ^7i.“272°C. .^kyla)/.- :; pavyzdys. + . .7-.' ' , . . Beksadecll.^.iperidinio74^il-fosfatas /;.;// / 7,1 ai (77 rainai) 'fssf.oro:/ofeichIori.dor:IštixpišaaBa;;^ įml sauso tetrahidrofurano ir atšaldoma iki 5-lQ°C'5 ...'. · Hydi temp-? Mp 272 ° C. . ^ rising) /.- : ; example. +. .7-. '',. . Bexadecyl. ^. Iperidine74 ^ yl-phosphate / ;,; / / 7.1 (77 irides) 'fssf.oro: /ofeichIori.dor: Extracted with dry tetrahydrofuran and cooled to 5-110 ° C.
:. tėaęjerątūEas-;/-/. kaišant lašinamas :;:^/i7./;-/-.:g./-;.;;<7S7.;/m®oi) heksadekanolio ir 48 ml trietilamino tirpalas 150 ml tetrahidrofurano. Po to maišoma dar 30 min., laikant ledo vonioje ir paliekama* · kad sušiltų iki kambario temperatūros„ 10,1 g (100 mmol). 4-piperidinolio:. father-in-law Thou -; / - /. drop by drop:;: ^ / i7./;-/-.:g./-;.;;<7S7.;/m®oi) hexadecanol and 48 ml triethylamine in 150 ml tetrahydrofuran. After stirring for an additional 30 min, keep in an ice bath and allow to warm to room temperature at 10.1 g (100 mmol). Of 4-piperidinol
207 ištirpinama;.!®Ū'/'ffll'/fcętrahidrdfwąhpįi/./sBmaIšdma-'/su/17 :ml trietilamino ir maišant, lašinama į reakcijos mišinį taip, kad· temperatūra nepakiltų virš 4G°C. Pabaigus .lašiaiš^'i^irinama su grįžtamu, .šaldytuvu vieną valandą•Iš dar karšto tirpalo nufiltruojamas trietilamonio207 Dissolve;.! ®Ū '/' ffll '/ fcętrahidrdfwąhpįi /./ sBmaIšdma -' / with / 17 : ml of triethylamine and with stirring, add dropwise to the reaction mixture so that the temperature does not rise above 4G ° C. At the end of this time, drop the solution in a reflux condenser for one hour • Filter the still hot solution with triethylammonium
257 chloridas., atšaldomas filtratas , ir maišant/išpilamas/į ledo·, ir 2 / B.. ;drirskos.:0./rūgštifi^0/ ;»isinįr/0../:Mšaldžius ' šaldytuve, . .iškrenta produktas;.jistirpinaaasmetileno chldride/Z džiovinamasMgSG4, /••/nugar/inamas/ -tirpikl i s ir ^chromatografuojama per · /silikagell,·;· .'elišentu naudojant .30 ,. metileno ·. chlorido/metanolio/25% amoniako + (7flį30 i5) mišinį. ; Frakcijos,-kuriose 'yra. /produktas, sn^pilafiKis kartu, ' nugarinamas ; tirpiklis ir ' kristalinama ' iš metanolio. Produktas džiovinamas vakuume viri P3O5,257 Chloride., Cooled filtrate, and stirring / pouring / into ice ·, and 2 / B ..; sprays.: 0./ acidic ./. ../: Freezing in refrigerator,. .dissolved product; .dissolved in methylene chloride / Z driedMgSG 4 , / •• / spin / solvent, and chromatographed on silica gel using .30,. methylene ·. chloride / methanol / 25% ammonia + (7fl3030). ; The fractions containing '. / product, sn ^ pilafiKis together, 'evaporated; solvent and 'crystallized' from methanol. The product is dried under vacuum over P 3 O 5 ,
A Plonasluoksnė chromatogr ama: . - ' .- (Ghloroformas/metanolis/25% /...'amoniakas '•..A' / 7 30:.20:10) ' . ?a_ -. \/'.a\?Thin layer chromatography:. - '.- (Ghloroform / methanol / 25% /...'ammoniac' • ..A '/ 7 30: .20: 10)'. ? a_ -. \ / '. a \?
' 7-' A 7 · Rf .” 0,42 ‘ . j, //.· / ll-batanolis/acto. rūgšti s/vanduo. 40:10,.:10)./'7-' A 7 · R f . '0.42'. j, //.· / ll-batanol / vinegar. acidic s / water. 40:10,.: 10) ./
A, . . R, « 0^33 ' 7 '7 7- A 7 ,/;'A,. . R, «0 ^ 33 '7' 7 7- A 7, /; '
10,. '. ' į , . - , . ./7. ;10,. '. 'to,. -,. ./7. ;
. -.3 pavyzdys ‘ .... -.3 Example '...
7...Ββ'Ϊ5.·3ΐ-βο11-(1Ύ·1-ά1.!ΰβίίΙρίρ·8Χΐάΐηχο·4·“11) fosfatas 15 7' 7c2SH52WR- '<461?,€4>..I320 ' y, . '· ' '?' ..,A '5,-7 g'- /{ii -.mmol) heksadecii’-pįperidiriįoi-4-il“fosfafo - - ištirpinama 10-0 ml metanolio ir sumaišoma? su. 11,#.6 .g --(8.4., , o - ' . ' a A d ---7,/ 7 ! imol) -.kalio/ karbonato. Intensyviai ..maišant,-, per 30 min»/ 2Q ! - sulašinama .·' 4,0 '7®! (42 mmol-) \ dimet'ilsulfąto. /PoAio// . .mišinys maišomas' 4 ' vai. 40°C temperatūroj®, atšaldomas, filtruojamas :' . ir nugarinamas.- Liekana / išsodinama . / acetonu, nusiurbiama ir tirpinamą 100..ml/··' $6% etanolio.: /Pridedama 15 g / jon.it© (ambęrlito MB ' 3) ir. maišoma 37 ... Ββ'Ϊ5. · 3ΐ-βο11- (1 Ύ · 1-ά1.! Ϋ́βίίΙρίρ · 8Χΐάΐηχο · 4 · “11) Phosphate 15 7 '7c 2S H 5 2WR-'<461 ? , € 4> .. I3 2 0 'y ,. '·'' ? '.., A' 5, -7 g'- / {-.mmol ii) heksadecii' pįperidiriįo i-4-yl "fosfafo - - 10-0 was dissolved in ml of methanol and mix? with. 11, # .6 .g - (8.4.,, O - '.' A A d --- 7, / 7 ! Imol) -.potassium / carbonate. Intensive .. with mixing, -, in 30 min »/ 2Q ! - dripping. · '4,0' 7®! (42 mmol-) \ dimethylsulfate. / PoAio //. .mixture '4'. At 40 ° C, cool, filter : '. and eviscerated.— Remains / settles. / acetone, suction and dissolving 100..ml / ·· '$ 6% ethanol. : / Adds 15g / jon.it © (amberrito MB '3) and. stir 3
2/5 valandas. Nufiltruojamas jęnitas, tirpalas nugarinamas'2/5 hours. Filter the yeast, evaporate the solution '
- ir ' /produktas perkristalinamas , : du. /..-kartus, 7'/iš .- and '/ product recrystallized : two. /..- once, 7 '/ of.
metiletilketono.methyl ethyl ketone.
. Džiovinamas vakuume virš Ρ2θδ· - '. Drying under vacuum over Ρ 2 θδ · - '
• 12• 12
60,/92% , 11,.26% . 3,0©% o-.60, / 92%, 11, .26%. 3.0 ©% o-.
Plonasluoksnė- ;cferotet^ogramr 7 '-, • '/-*/' 7 <e&l©rofQXKias/ffletąSi0:llsZ2S% . amoni a kas . / /70120:10} < ,' 7 ' -7 .' / ¢/28/7 / .. =Thin-film-; cferotet ^ ogramr 7 '-, •' / - * / ' 7 <e & l © rofQXKias / ffletąSi0: llsZ2S%. amoni a what. // 70120: 10} <, '7' -7. ' / ¢ / 28/7 / .. =
3^=- ::4-^7.././:/^:^:=4^.3..3- 7 /': .7 /-,.:3 ^ = - :: 4- ^ 7 .././:/^:^:= 4 ^ .3..3- 7 / ': .7 / -,.:
7- / - /230¾;Įskyla),..- ' ' ' · / 7 :=4.7 ' 7---3/. .7/ :--3-- =4:--./=.7:7 -..7-- .-.7- / - /230¾;Includes :),..- '' '· / 7: = 4.7' 7 --- 3 /. .7 /: - 3-- = 4: --./=. 7: 7 - .. 7-- .-.
:.4/pavyzdys / ,...7.7:''-'/ ;-grueil--(l;,:l~dimętilplpęrldlnio-l-ii-j. fosfatas ’ .: .4 / example /, ... 7.7: '' - '/; -grueil - (l ;,: l -dimethylplpetrldlnio-l-ii-j. Phosphate'.
iV ' ' 15 .-/,,02,^^1^^::(515,7651 .h2o ·///= - /i//:iV '' 15 .- / ,, 02, ^^ 1 ^^: :( 515,7651 .h 2 o · /// = - / i //:
' .10,3- rū :-(07ΐ1:·«ο11 fosforo oksichlorido-./idedama į 5©. ai . , chloroformo ir :3-~į©°C temperatūroje sulašinamas :32* S g (©,1© moli/.-arūc-įlo,alkoholio it1 32 ml piridino 7 tirpalas'.10,3- kind :-( 07ΐ1: · «ο11 phosphorus oxychloride- / added to 5 © s., Chloroform and: 3- ~ to © ° C drip: 32 * S g (©, 1 © mole /.- aruc bay, alcohol, and 1 32 ml pyridine 7 solution
-= 100. ei. :-ehi:OrQfox®G> /Kaišoma pusę valandos ix pridsdsma , įš - -karto 4 35,-2' /-g: (0,13 ssol) 4^idroksi-=2^i--^imefil^- = 100. no. : -ehi: OrQfox®G> / Pitched for half an hour ix pridsdsma, in - - fold 4 35, -2 '/ -g: (0.13 ssol) 4 ^ idroxy = 2 ^ i - ^ imefil ^
7-piporiciiaio-kpe^iiafco-': Po to sulašinama 40 ./faridino-.,. leidžiama sušilti iki kambario temperatūros ir maišoma dar 3 valandas;..:.-7Bo. :tp.4.,4hidtelizuojama .. .15/ ml ./vandens,. 25 -. ,s^šaht7:dar=pese//'W/an^ds,=4ir7įiha^ama;:vąnd^s/;mtahpl-io7-piporiciiaio-kpe ^ iiafco- ': This is followed by a drip of 40 ./faridino -.,. allowed to warm to room temperature and stir for a further 3 hours; ..: .- 7Bo. : tp.4., 4hydrolysed .. .15 / ml ./water,. 25 -. , s ^ shah7: else = pese // 'W / an ^ ds, = 4ir7? iiha ^ ama ;: vąnd ^ s /; mtahpl-io
4-(1.:11, - 73%. ;pafcm /karkbhsto/^tizp^ .įltįj;,;-. 3% .7.-:/-:;c±triBas. (1»1) ir:: -;vahdmsZwfcaiB3lih : (1:1) 4 :sišihxais47:/<p©/: :1W: > ml 1 · Grgaa.inis - 4.··.sluoksnis '-.nugarinamas,:. 4;:i&':.iiėkan<3š7 išsodinama medžiaga., 7 pridedant ' acetono, = ir 7/tirpinama-..: 150 = :jįl:/36%//alasolio.7 Tirpalas .maišomas '3 valandas: su 20„g jonito /famberįite/RB3) ir .nuskaidrinamas;, -filtruojant per .'.-Biėsėlgurą. Nugarinama 1 ir chromatografuo jama per / /silikagelį., eliuėntu naudojant chlorofdrmdZitetanQlioZ25% amoniako (70:40:10) mišinį. .- Produktą turinčios frakci jos supilamos kartu ir vakuume sausai išgarinamas tirpiklis. ·4- (1.:11 - 73%.; Pafcm / karkbhsto / ^ ^ tizp .įltįj;, -. 3% .7 .-: / -: c ± Tribe. (1 »1), and :: -; vahdmsZwfcaiB3lih: (1: 1) 4: siihihaisais47: / <p © /:: 1W:> ml 1 · Grgaa.inis - 4. ·· .layer '-.layer,:. 4;: i &':. to <3x7 precipitated material, 7 with addition of 'acetone, = and 7 / solubilized - ..: 150 =: solution: / 36% // alasol.7 Solution .mixed' for 3 hours: with 20 g of ion exchanger / RB3 ) and .cleared ;, -filtering through .'.- Beetroot. Evaporate 1 and chromatograph over silica gel eluting with chloroform / 70% ammonia (70:40:10). The fractions containing the product are combined and the solvent is evaporated to dryness in vacuo. ·
Išeigas 4,4 g (9%)'·. · -Yield 4.4 g (9%). · -
Plonasluoksnė chromatograma: 5 (chlorofoiraas/metanolis/1 M natrio acetatasThin layer chromatogram: 5 (chloroform / methanol / 1 M sodium acetate)
25% amoniake 70:20:10) r Rf =0, 30, .....25% ammonia 70:20:10) r R f = 0, 30, ......
pavyzdys .. R.example .. R.
io · ' - ...... - ' R / . :Heksadecil-(1,l-dimetilpiperidlnio-3-il)fosfatas 'Ο23Η4@ΝΟ^Ρ, -(433,616) .H2O . . * . //++.: +.io · '- ...... -' R /. : Heksadecil- (1, l-dimetilpiperidlnio-3-yl) phosphate 'Ο23Η ΝΟ 4 @ Ρ ^, - (433.616) .H 2 O. . *. // ++ .: +.
'15 10,3 ml (0,11 mol) fosforo o'ksichlotido įdedama +į /50 ml chloroformo ir atšaldoma iki 0—10°C temperatūros. 24,2 c +(0,10 REnolJ n-heksadekanolio ištirpinama 100 ml »· chloroformo, sumaišoma' su 32 ml piridino ir per pusę valandos, šaldant ledu, sulašinama į fosforo oksichlorido + tirpalą. R Maišoma dar pusę valandos,r; pridedama iš ,karto 39,2 g (0,13 mol) 3-hidroksίτΐ,ΐdimetįlpiperidinio tosilato ir kambario/ “temperaturoj e per 15 min. sulašinama 40 ml piridino. Mišinys maišomas ’kambario temperatūroje .16/ valandų, po to hidro/25 lizuojamas 15 ml vandens, maišant /dar pusvalandį, ir plaunamas vandens/metanolio (1:1), 3%. natrio karbonato tirpalo/metanoįio (1:1), 3% citrinos rūgštiės/metanolio (1:1) ir vandens/metanolio (1:1-) miš iniais (po 100 ml ) R Organinis sluoksnis džiovinamas natrio sulfatu ir nugarinamas. Liekana tirpinama 150 ml - 96% etanolio, nufiltruojama ir filtratas maišomas su .jonitu (amberlitu MB 3). Jonitas nufiltruojamas, tirpalasAdd 15.3 ml (0.11 mol) of phosphorus oxychlotide + to / 50 ml of chloroform and cool to 0-10 ° C. 24.2 c + (0.10 REnol) n-hexadecanol is dissolved in 100 ml of chloroform, mixed with 32 ml of pyridine and added dropwise over half an hour under ice-cooling to a solution of phosphorus oxychloride +. of 39.2 g (0.13 mol) of 3-hydroxyethyl, dimethylpiperidine tosylate and 40 ml of pyridine are added dropwise at room temperature over 15 minutes. The mixture is stirred at room temperature for 16 hours, then hydro- 15 ml of water with stirring / for another half hour and washed with water / methanol (1: 1), 3% sodium carbonate solution / methanol (1: 1), 3% citric acid / methanol (1: 1) and water / methanol ( 1: 1-) (100 ml) R Dry the organic layer over sodium sulfate and evaporate to a residue, dissolve the residue in 150 ml - 96% ethanol, filter and mix the filtrate with ion exchanger (amberlite MB 3).
(-/(chloroformasAtetanolisZl·-· Μ .natrio- acetatas /-'('(7 <25%/.amoniake-· 70:40:10) 10 -/'('i%/=X0,37. 7(/ .-//7/· /(- / (chloroformAethanolZl · - · Μ. sodium trioacetate / - '(' (7 <25% /. ammonia- · 70:40:10) 10 - / '(' i% / = X0.37. 7 ( / .- // 7 / · /
--c & pavyzdys ’-' / /-7. 7/-7 ' O k t adėci I — (iT1 ~dimet i Iplper idini o-3 - j I) fosfatas ' 15 ('(λ/ 1(//- (/ /-//.//(, /GaUnamas;-7pagai/0./^vyzdyje-·., aprašyta'-tetodiką^ iš TO, 3 ml <0,I1'. /^1>/ 'fosforo< oksichlorido:,/··.27,0 '.g <0,10 mol) oktadekanolįo, 722+40/ ml piridinio ir /39.,.2 g (0,13 mol) 3~hidroksi-l,l-di®etilpiperidinio (tėziiato.--c & example '-' // // -7. 7 / -7 'O kt Adici I - (i T 1 ~ dimet i Iplper idini o-3 - j I) Phosphate' 15 {'(λ / 1 {// - {/ /-//.// {, / GaUnam ; -7pages / 0 ./^ in the example- ·., Described'-tetodic ^ from TO, 3 ml <0, I1 '. / ^ 1>/' phosphorus <oxychloride:, / ·· .27,0 ' g (0.10 mol) of octadecanol, 722 + 40 / ml of pyridine and 39.3.2 g (0.13 mol) of 3-hydroxy-1,1-di-ethylpiperidine (thiazate).
. Išeiga: 18,7 g (40%) ;. Yield: 18.7 g (40%);
/ Pįonaslųokšnė chromatograma:/ Pore-layer chromatogram:
(ehloroformasZmetanoIisZT M natrio acetatas 25% amoniake 70:40:10)(EchloroformZmethaneIisZT M sodium acetate 25% ammonia 70:40:10)
Rf =» 0, 35.. · ' 7 pavyzdysR f = »0, 35 .. · 'Example 7
Hėksadecil-(l,l-dimetilpiperidinio-2-il)fosfatasHexadecyl- (1,1-dimethylpiperidin-2-yl) phosphate
C24H5ON04P (447,643) .1/2 H2OC 24 H 5O N0 4 P (447.643) .1 / 2 H 2 O
Gaunamas pagal 5 pavyzdyje aprašytą metodiką iš 10,3 ml (0,11 mol) fosforo oksichlorido, 24,2 g (0,10 ,aol) heksadekanolio, 32+40 ml piridino ir 41,0 g (0,13 mol)Prepared according to the procedure of Example 5 from 10.3 ml (0.11 mol) of phosphorus oxychloride, 24.2 g (0.10, aol) of hexadecanol, 32 + 40 ml of pyridine and 41.0 g (0.13 mol).
2-hidroksimetil-1,1-dimetilpiperidinio tozilato.2-hydroxymethyl-1,1-dimethylpiperidine tosylate.
Plonasluoksnė chromatograma:Thin layer chromatogram:
(chloroformas/metanolis/1 M natrio acetatas 25% amoniake 70:40:10) , Rf - 0,47.(chloroform / methanol / 1 M sodium acetate 25% ammonia 70:40:10) R f - 0.47.
8 pavyzdysExample 8
Oktadecil-(1,l-dimetilpiperidinio-2-il)fosfatasOctadecyl- (1,1-dimethylpiperidin-2-yl) phosphate
C26HmNO4P (475, 697) .1/2 H2OC 26 H m NO 4 P (475, 697) .1 / 2 H 2 O
Gaunamas pagal 5pavyzdyje aprašytą metodiką iš 10,3 ml (0,11 mol) fosforo oksichlorido, 27,0 g (0,13 mol) oktadekanolio, 32-40 ml piridino įr 41,0 g (0,13 mol)Obtained according to the procedure described in Example 5 from 10.3 ml (0.11 mol) of phosphorus oxychloride, 27.0 g (0.13 mol) of octadecanol, 32-40 ml of pyridine and 41.0 g (0.13 mol).
2-hidroksimetil-1,1-dimetilpiperidinio tozilato.2-hydroxymethyl-1,1-dimethylpiperidine tosylate.
Išeiga: 23,9 g (50%) ‘ !Yield: 23.9 g (50%) '!
Ęlementinė analizė:. CStage Analysis:. C
Išskaičiuota: 64,43%Discount: 64.43%
HH
11,44%11.44%
NN
2, 89%2, 89%
Rasta :64,50% 11,61% , 64,11% · ·/· 5/ 5' . ; '7.Found: 64.50% 11.61%, 64.11% · · / · 5/5 ′. ; '7.
5'·' ' ··' ’ - / ·'- '' '· ? ' ·' 5..·· ·5 '·' '··' '- / ·' - '' '·? '·' 5 .. ·· ·
Plonasluoksnė chrometograma:Thin-layer chrometogram:
2,67%2.67%
11,49%11.49%
2,77%2.77%
K. natrio acetatasK. sodium acetate
..25%. saoniafe//70r40/: .Rf ~ 0,47; .. ii..25%. saoniafe // 70r40 /: .Rf ~ 0.47; .. ii
Bėkgadecįl-(1,l-dlmetilpiperidinio-3-il·)fosfatasBACKGROUND OF THE INVENTION 1- (1,1-Dimethylpiperidin-3-yl ·) phosphate
C24HS0M)4P (447, 643). 1C 24 H S0 M) 4 P (447, 643). 1
Gaunamas.;.pagal:;:5-/pavyzdyje . aprašytą metodiką iš l&,&. ml (0,11 mol) fosforo oksichlorido, 24,2 g (0,10 mol) h&ksaefefenolio, 32t4Q ml piridino ir 41,0 g (0,13 mol)Incoming.;. By:;: 5- / in the example. the methodology described from l &, &. ml (0.11 mol) of phosphorus oxychloride, 24.2 g (0.10 mol) of h & a-xaephephenol, 324 ml of pyridine and 41.0 g (0.13 mol)
3-hidrpfesim@til-“l>lrdimetilpiperidinio t02ilato. ' J : Išeiga; 17* 2; g..3-Hydrpfesim @ 1-ylmethyl-methylpiperidine-2-ylate. 'J: Yield; 17 * 2 ; g ..
7· Rlementinė-analise;· :Rastat7 · Rastat-analise; ·: Rastat
/natrio ^acetatas '/ sodium ^ acetate '
'./,25%·.. amoniake .-.lOtMi Rf ® 0/29 pavyzdys'./,25%· .. ammonia .-. LOtMi R f ® 0/29 Example
Oktadecil-(l, l-dimetllpiperldinlo-5-il) fosf atasOctadecyl- (1,1-dimethylpiperldinyl-5-yl) phosphate
C26H54NO4P (475,697) .H20C 26 H 54 NO 4 P (475,697) .H 2 0
, 17 . ., 17th .
Gaunamas pagal 5 pavyzdyje aprašytą metodiką iš 10, 3 ml (0,11 /mol) oktadekanolio, 32-40' ml piridino ir 41,0 g /(©,13 mol) 3-Hidroksimefcil-l, 1-dimetilpipėridinio tozilato.Prepared according to the procedure of Example 5 from 10.3 ml (0.11 / mol) octadecanol, 32-40 'ml pyridine and 41.0 g / ml (13 mol) 3-hydroxymethyl-1,1-dimethylpiperidine tosylate.
Išeiga: 16,7 g (35%) ,-Yield: 16.7 g (35%), -
. 10 /(chlotoformas/metanolis/1''- :M/ ./natrio----acetatas'.'-'/7./Y(.(-k/(7..:.25% -'amoniake'..70:40:-10) / y/y/'/./'<. 10 / (chlotoform / methanol / 1 '' -: M / ./sodium----acetate'.'-'/7./Y(.(-k/(7..:.25% -'amoniake ') ..70: 40: -10) / y / y /'/./ '<
...(y/; )'Rf «... 0, 30 .-.):,/(/171-1-.-/pavyzdys.' ////) . -:--.15 ) k /.(-.' '/'( /('(' -.Y y, 7'.’ / )'/-''(.('//: //'-/' (;kk y .Tetradecil-(1,l-dimetilheksahidroazepinio-4-il)fosfatas... (y /;) 'R f «... 0, 30 .-.):, / (/ 171-1 -.- / example.' ////). -: -. 15) k /.(-. '' / '(/ ('('-.Y y, 7'. '/)' / - '' (. ('//: //' - / '(; kk y. Tetradecyl- (1,1-dimethylhexahydroazepin-4-yl) phosphate
Y.:,/ -:e2sH4>D4>/-'(410,54)'.B20'-7. (' )/....:( .(/c/ k/.'Y.:,/ -: e 2 sH4> D 4 > / - '(410.54)'. B 2 0'-7. (') / .... :(. (/ c / k /.'
-/20--/-- '/'/(Gaunaffias:-/pagai::5:-':pavyzdyjė)/iapraš.ytą:-/attetodi.ką(.iš 9, 6 (9/./-7 (45 mmol) tetradekanolio, 4,6 ml (50 aimol)/ fosforo ./.(.-okšicliloiido,-' 10 - 20 ml . piridino ir 21,3 g (67,5 mmol) hidroksi-l,l-dimetiltetrahidrodiazepinio tozilątoc ;-7 --/'( Valomasekspres-chromatogiaf i jos /./būdu -. per šilikageli, /( 25 /eliuentu /naudojant metileno chlorido/metanoli0/25% / amoniako 70:40:10 mišinį.- / 20 - / - '/'/(Gaunaffias:-/pages::5:-':example)/written:://attetodi.ko(.of 9, 6 (9 /./- 7 (45 mmol) of tetradecanol, 4.6 ml (50 aimol) / phosphorus / 10- 20 ml of pyridine and 21.3 g (67.5 mmol) of hydroxy-1,1-dimethyltetrahydrodiazepine tozilątoc; -7 - / '(Valomasekspres-chromatogiaf its /./būdu -. silica gel / (25 / gel / methylene chloride / metanoli0 / 25% / ammonia 70:40:10 mixture.
Išeiga: 2,70 g (15%)Yield: 2.70 g (15%)
Plonasluoksnė chromatograma:Thin layer chromatogram:
- (chlaroformas/metanolis/1 M natrio acetatas- (Chloroform / methanol / 1 M sodium acetate
25% amoniake 70:40:10) > Rf = 0,30 , , . y:'·. ·’·>. r · > (1-butanolis/acto rūgštis/vanduo 40:10:10)25% ammonia 70:40:10)> R f = 0.30,. y : '·. · '·>. r ·> (1-butanol / acetic acid / water 40:10:10)
Rf — 0,08 * Heksadecil-(1, l-dimetlIfaeksahldroa2epirio-4-ll)fosfatasRf - 0.08 * Hexadecyl- (1,1-dimethyl-1-hexa-hexahydro-2-pyriro-4-yl) -phosphate
C24H4eK04P (445,62)C 24 H 4e K04P (445.62)
Gaunamas 'pagal 5 pavyzdyje -aprašytą inetodiką iš 10,8 g (45 mmol) heksadekanolio,/ .4,6 ml (50 zanol) fosforo oksichlorido, 10+20 ml piridino -ir 21,3 g (67,5: mm©i)Obtained according to the procedure described in Example 5 from 10.8 g (45 mmol) of hexadecanol, 4.6 ml (50 zanol) of phosphorus oxychloride, 10 + 20 ml of pyridine and 21.3 g (67.5: mm © i)
4-hidroksl-l, 1 -dimetilheksafaidieazepinio - tozilat©. ..Valomas -ekspres-cbromatografljos . feodu per/.-silikagelį, eliuentu naudojant metileno c'hlorido/met;anolio/25% amoniako 70:30:10 mišinį.4-hydroxy-1,1-dimethylhexaphaideazepinyl tosylate ©. ..Cleared -express chromatographies. feodor over silica gel eluting with methylene chloride / methanol / 25% ammonia 70:30:10.
Išeiga: 5,0 g (25%) Elementinė analizė-:Yield: 5.0 g (25%) Elemental analysis-:
Išskaičiuota:Excluded:
Rasta:Found:
Plonasluoksnė chromatograma:Thin layer chromatogram:
(chloroformas/metanolis/25% amoniakas(chloroform / methanol / 25% ammonia
80:25:5) 7 >0,10 ' (1-butanolis/acto rūgštis/vanduo 40:10:10)80: 25: 5) 7> 0.10 '(1-butanol / acetic acid / water 40:10:10)
Rf ® 0,10R f ® 0.10
Lyd. temp.: 250°C (skyla)Lyd. temperature: 250 ° C (decomposes)
LT 311 pavyzdysEN 311 Example
Okt .decil- (l,l-dimetilheksahidroazepinio-4-Il)fosfatas 'Oct. decyl (1,1-dimethylhexahydroazepin-4-yl) phosphate '
C26H54NO4P; (475,695).1/2 H20C 26 H 54 NO 4 P; (475,695) .1 / 2 H 2 0
Gaunamas pagal 5 pavyzdyje aprašytą metodiką iš 12/1 g/ (45 mmol) oktadekanolįo, 4,6 ml (50 mmol) fosforo oksichlorido, 10+20 ml piridino ir 21,3 g (67,5 mmol)Prepared according to the procedure in Example 5 from 12/1 g / (45 mmol) octadecanol, 4.6 ml (50 mmol) phosphorus oxychloride, 10 + 20 ml pyridine and 21.3 g (67.5 mmol).
4-hidroksi-l, l-dijnetilheksahidroazepinio tozilato. Valomas ekspres-chromatografijos būdu per silikagelį,/ 'eliuentu naudojant metileno .chlorido/metanolio/25% amoniako 70:30:10 mišinį.4-hydroxy-1,1-dimethylhexahydroazepine tosylate. Purify by silica gel flash chromatography eluting with 70:30:10 methylene chloride / methanol / 25% ammonia.
(chloroformas/metanolis/l M natriu acetatas 20 25% amoniake 70:40:10) / ' ' Rį = 0,22(chloroform / methanol / l M sodium acetate 20 25% ammonia 70:40:10) / '' R f = 0.22
Lyd. temp.: 250°C (Skyla)Lyd. temperature: 250 ° C (Skyla)
14 pavyzdys .Example 14.
cis-A9-OktBdecenll-(1,l-dimetilheksahidroazeplnio-4' ii)fosfatas 30 C26H52NO4P (473, 679) .H20cis-A 9 -OctBBdecenyl- (1,1-dimethylhexahydroazeplenio-4 'ii) phosphate 30 C 26 H 52 NO 4 P (473, 679) .H 2 0
Gaunamas pagal 5 pavyzdyje aprašytą metodiką iš 12,1 g/ (45 mmol) cis-As-oktadecenolio, 4,6 ml (50 mmol)Is obtained according to the procedure described in Example 5 from 12.1 g / (45 mmol) of cis--oktadecenolio A s, 4.6 ml (50 mmol) of
LT 3113 JB fosforo oksichlorido, 10+20 ml piridino įr 21,3 g (67*5 mmol) 4-hidroksi-l*l~dimetilheksahidroazepinio tozi lato* Valomas ekspres-chromatografijos būdu per silikageįį* eliuentu naudojant metileno chloridą/metanolį/25%EN 3113 JB Phosphorus oxychloride, 10 + 20 ml pyridine, 21.3 g (67 * 5 mmol) 4-hydroxy-1 * 1-dimethylhexahydroazepine tosylate * Purification by silica gel chromatography using methylene chloride / methanol as eluent / 25 %
-5 . / amoniaką 70:30:10./ ../,+7..+/. .-5. / ammonia 70: 30: 10./ ../,+7..+/. .
Išeiga: 4,5 g (21%)Yield: 4.5 g (21%)
/ Plonasluoksnė ohrOmafe ograma: 7./7 .,/7-.,+/.-.-:/7/ / +. , -.(chloroformaš/metanolįs/25% amoniakas + . '+-+ 70:40:10) į 7/2 ';+ / 7 7-- /7 7 +/ Thin film ohrOmafe ogram: 7./7., / 7 -., + /.-.-: / 7 / / +. , -. (chloroform / methanol / 25% ammonia +. '+ - + 70:40:10) to 7/2'; + / 7 7-- / 7 7 +
/.7//,- Rf®0*28 ' 4-:/7/- /7/../ . ./.7//,- R f ®0 * 28 '4 -: / 7 / - /7/../. .
. /-, 7(1-butanolis/acto. rūgštis/vanduo 40:10:10) IS-'·/-' - ./ / Rf=0,10 /-/' 7 -,--'.-. 7 .- / 15 pavyzdys /' - /7 ·' . . + #4 / Sikozil^ (i* t-dimetilheksah.idrgazepinio-4-il) fosfatas. / -, 7 (1-Butanol / Acetic. Acid / Water 40:10:10) IS- '· / -' - ./ / R f = 0.10 / - / '7 -, --'.-. 7 .- / Example 15 / '- / 7 ·'. . + # 4 / Sicosyl ^ (i * t-dimethylhexahydro-gaspepin-4-yl) phosphate
- · .½ 20 7. '- · .½ 20 7. '
Cz8H58m4P (503*754) .B2P + ' +Cz 8 H 58 m 4 P (503 * 754) .B 2 P + '+
Gaunamas pagal.,-+5: pavyzdyje aprašytą metodiką iš 13/4 g (45 mmol) eikoząnolio* 4*6 ml (50 mmol) fosforo oksichlorido* 10+20 ml piridino ir 21*3 g(67,5 mmol) 4-hidroksi“!* 1-dimetilheksahidroazepinio tosilato/Obtained according to the procedure described in the example, + 4: 13/4 g (45 mmol) of eicosanol * 4 * 6 ml (50 mmol) of phosphorus oxychloride * 10 + 20 ml of pyridine and 21 * 3 g (67.5 mmol) of 4 -hydroxy! * 1-dimethylhexahydroazepine tosylate /
Valomas ekspres-chromatograf Įjos būdu per ,/sllikagelį, eliuentu naudojant metileno chlorido/metanolio/ + 25% amoniako70:30:10 mišinį.Purify by flash chromatography on silica gel using methylene chloride / methanol / + 25% ammonia 70: 30: 10 as eluent.
Išeiga:5*7 g (25%)Yield: 5 * 7 g (25%)
Elementinė analizė: + + C ,Elemental analysis: + + C,
Išskaičiuota: 64,46%Discount: 64.46%
H NH N
11,59% - 2,68%11.59% - 2.68%
O 3113O 3113
Rasta: 63,51%Found: 63.51%
64,00%64.00%
11,48% 2,95%11.48% 2.95%
11,79% 2,91%11.79% 2.91%
Plonasluoksnė chromątograma:Thin-layer chromogram:
+70:40:10) +./ ,· ·' . '+70: 40: 10) +. /, · · '. '
Rf = 0,12 .R f = 0.12.
pavyzdys . + +/ ' ./---,. .+.10 +/ +. + (grugll -+(1, l-Mmeti+lĖekšahidr0azepinio-*4~;il) f os f atas y- '// /C^o®^+.(510, 789) .H20 7,example. + + / './---,. . +. 10 + / +. + (grugll - + (1, l -Mmeti + lExahydro-azepine- * 4 ~; il) f os f atas y- '// / C^o® ^ + .(510, 789) .H 2 0 7,
Gaunamas pagal 5 pavyzdyje aprašytą metodiką iš 16,2 g 15 +. (50 mmo-1) yerucilo//-aį+kgholi©.//· +5,1 ml (55 mmol) fosforo oksichlorido,+18 + +30 ml piridino ir/20,5 g (65 mmol)Obtained according to the procedure described in Example 5 from 16.2 g of 15 +. (50 mmo-1) yerucil // + kgholi © .// · + 5.1 ml (55 mmol) phosphorus oxychloride, + 18 + + 30 ml pyridine and / 20.5 g (65 mmol)
4~’+hidrokšl-l, į-dimetįlhėkšahįdrpažė+pįnio tozilato. Valomas ekSprės-chr omatogpafi jos - + būdu + . per s i 1 i kage 1 į, eliuentu+'+'+-:.i+-6auidPjant-++·./''.-mėti+iėfio·' chlorido/metanolio/25% į- amoniako/70/-+30+:+10 ...mišinį.+ .+:4 ~ '+ hydroxyl-1,1'-dimethylhydroxyl + pentos tosylate. Cleaned by extras-chr omatogpafi - + method +. per si 1 i cage 1 in, eluent + '+' + -:. i + -6auidPjant - ++ · ./''.- throw + iffium chloride chloride / methanol / 25% ammonia / 70 / - + 30+ : +10 ... mix. +. +:
• to• to
+ . Plonasluoksnė clirbmatograma: + - 7.+. Thin-layer clirbmatogram: + - 7.
' ; (čhloroformas/metanolis/l M natrio ; acetatas 25% amoniake 70:40:10)'; (Chloroform / Methanol / L M Sodium; Acetate 25% in ammonia 70:40:10)
Rf = 0,30R f = 0.30
-ii) fosfatas pavyzdys'-ii) Example of phosphate '
Gfetacfeci.1oGfetacfeci.1o
-Gamas^· pegal/5'pavyzdyje .-^aašytą ®etodifeą 3,25% g - (I2/'.®b^l/./;afetadėtenolio, / -1,2.1. >1 / 113' to>1) ..fosforo ©ksiefelorddo,; /3/7. + 4,-8/»l; -piridino ir. 4,33-. g <15 lamol) 10 . / Mdrofesi“l>ii-diffletilpiroliddnA.o /- tozilato. ' λ '.-Išskirtas - .' 'produktą^. 'valomas,.'. / tirpinant -./95% /< etanolyje ir >·. apdaroj.aat; jonita. (aafcerlifu HB 3)..-Gamma ^ · pegal / 5'in the example .- ^ spelled ®ethodife 3.25% g - (I2 / '. ®b ^ l /./; aphaetenetenol, / -1,2.1.>1/113'to> 1 ) ..phosphorus © ksiefelorddo,; / 3/7. + 4, -8 µl; -pyridine and. 4.33-. g <15 lamol) 10. / Mdrofesi 'l> i i -difflethylpyrroliddnA.o / - tosylate. 'λ'.-Excluded -. ''product ^. 'cleansed,.'. / by dissolving -./95% / <in ethanol and> ·. trim; Jonita. (aafcerlifu HB 3) ...
(chloro-forates/«fam.liš/l :/M· natrio /acetatas :_./. -. 25% /amoniake 70,:40-:10) / 20· ' iU/= 0/25 / ,'.''/ .-Makė-adec^^2^.i.trTTdifflefįipirQlidinici^.2--i.l:iet±l:fo.sfatas(chloro-forates / «fam.liš / l: / M · sodium / acetate: _. /. -. 25% / ammonia 70,: 40-: 10) / 20 · 'iU / = 0/25 /,' . '' /.-Mache-adec ^^ 2 ^ .it r TTdifflefąipirQlidinici ^ .2 - il: iet ± l: fo.sfatas
C^Bso^P <447,543). H20C ^ Bso ^ P <447,543). H 2 0
Gaunamas.....pagal. 5 ..pavyzdyje aprašytą. metodiką, iš 9» 21 gIncoming ..... by. 5 .. described in the example. methodology, of 9 »21 g
’.....(38 :. mmoll'”?-heksadekanolio.,//3.-,9../ ml (42 mmol) fosforo'..... (38: .mmoll'' ? - hexadecanol.) // 3 .-, 9 ./ml (42mmol) phosphorus
Oksichlorido, 13 + 16 ml piridino ir 15,/8 g <50 mmol) 2-<2-hidroksietil)-l,ldimetilpIrolidinio - tozilato. Išskirtas produktas·, valomas , tirpinant 96% etanolyje ir apdorojant j©nitu (amberlitu . . . 23 /Oxychloride, 13 + 16 ml of pyridine and 15, (8 g <50 mmol) of 2- <2-hydroxyethyl) -1,1-dimethyl-pyrrolidine-tosylate. The isolated product · is purified by dissolving in 96% ethanol and treating it with amberlite.
Išeiga: 6,0 g (35%) ' . .BYield: 6.0 g (35%). .B
>/-.,·..Bldndslūoksnė chromatograma: . ' '.* v ' :. . . '· · ; λ' .> / -., · ..Bldnd slice chromatogram:. ''. * v ':. . . '· ·; λ '.
') ... (dfelorofoms/mętanolis/1 .M. - natrioacetatas //)'.' /y ) ;25%yamoniake· 70:40:10) /-y..') ... (dfelorophoms / methanol / 1 .M. - sodium acetate //)'. ' / y) ; 25% yamoniake · 70:40:10) / -y ..
- '. 7/.· .&£/“ 0,38' ·/..·/' •'•19 pavyzdys· . · / ·./.'- io. .b /' ' '.·. ~ '/ B β.37):β.β·β·'.'β • : g-fefadegll^-ž'-l., 1 -dimetilplrolldinio-l-il) etilf osf atas >.: . '{475/697} ,1/2. \ ' ///'- '. 7 /. ·. & £ / "0.38 '· / .. · /' • '• Example 19 ·. · / · ./.'- io. .b / '''. ·. ~ '/ B β.37) : β.β · β ·'. 'Β •: g-fefadegll ^ -ž'-l., 1 -dimethylplrolldinio-l-yl) ethylphosphate>. : . '{475/697}, 1/2. \ '///'
1'5 metodiką iš 10,3 gMethod 1'5 of 10.3 g
-/y {38 m&olloktądekanolio,.' 3 .j/·9./) ml··· (42 mmol) fosforo i/pksichiorįdoll3 // lO-mi-piridino· jr ·15,·8;·<//50?/ίΒ®ηο1) 2~- / y {38 m & olloct decanol,. ' 3 .j / · 9. /) Ml · ·· (42 mmol) phosphorus i / pxychioridoll3 · lO-mi-pyridine · jr · 15, · 8; · <// 50 ? / ίΒ®ηο1) 2 ~
7:0<,//;;(2'^hidroks.iėtil.)..-'-l.,.$“dimefiIpirolidinio/'/to.zilato. Išs.'kirtas'')/-pfodu.ktas va lomas, tirpinant .96%/eta»olyje- ir ·7: 0 <, // ; ; (2 '^ hydroxyethyl) ..-'- l., $' DimefiIpyrrolidine / '/ to.zilate. Purified by '') / - pfodu.ktas is made by dissolving .96% / eta »in ol- and ·
{chloroformas/metanolis/! M natrio acetato 25% amoniake 70:40:10){chloroform / methanol /! M sodium acetate 25% ammonia 70:40:10)
Rf « 0,35 'R f «0.35 '
oo
Heksadecil- (lr 1-diaie t i lpirol idinio-2-ii ) met il f osf atasHeksadecil- (I r on the following one-to lpirol Idina-2-yl) met yl OSF report f
- / Ą3H48M)4P (433* 616) . 1/2 Hp- / ą 3 H 48 M) 4 P (433 * 616). 1/2 Hp
Gaunamas pagal 75 pavyzdyje aprašytą /metodiką iš 9,21 g (38 mmol) heksądefcanolio*; 3,9 -ml (42 mmol) fosforo oksichlorido, 13 + 16 mi piridino’ ir 15*1 g (50 mmol)Obtained according to the procedure described in Example 75 / from 9.21 g (38 mmol) of hexa-deccanol *; 3.9 mL (42 mmol) of phosphorus oxychloride, 13 + 16 mL of pyridine 'and 15 * 1 g (50 mmol)
2-hidroksįmetiI/l*l-dimetilpirolidinįo tozilato. Produktas -valomas* tirpinant 96% etanolyje ir apdorojant jonitu (amberlitu MB 3) , 7 ..-7---/7Išeiga: 8,3/g (51%)2-hydroxymethyl / l * l-dimethylpyrrolidine tosylate. The product is purified * by dissolution in 96% ethanol and treatment with ion exchanger (amberlite MB 3), 7 ..- 7 --- / 7 Yield: 8.3 / g (51%)
Elementinė analizė: // C///'/' / /./ / N .Elemental Analysis: // C /// '/' / /./ / N.
: 15 <// ////., /A.,·/ ': 15 <// ////., /A.,·/ '
Plonasluoksnė chromatograma: / , (chloroformas/metanolis/1 M natrio acetatas 25% amoniake 70:40:10)· . : 'Thin layer chromatogram: /, (chloroform / methanol / 1 M sodium acetate in 25% ammonia 70:40:10) ·. : '
-<///,/////lA =0*33 /////' ··'. //. 21 pavyzdys- <///, ///// lA = 0 * 33 ///// '··'. //. Example 21
Oktadecll- (1 * 1-dimetilpirolldiniQ-2-il)metilfosfatas ·<·?/\';. 7^·///- -77 A /A ;//·---A·... /-/.7/- . . / / C25H52NO4P (461* 67) . 1/2 H20Octadecyl- (1 * 1-dimethylpyrrolidin-2-yl) methyl phosphate · <· ? / \ ';. 7 ^ · /// - -77 A / A; // · --- A · ... /-/.7/-. . // C 2 5H 52 NO 4P (461 * 67). 1/2 H 2 0
Gaunamas/pagal 7; 5 pavyzdyje aprašytą metodiką iš 10/3 g / (38 mmol) oktadėkanolio* 3,9 ml/ (42 /Bimol) ^fosforo //oks i chlorido, 13 + 16 ml piridino ir 15,1 g (50 mmol) 2-h.idroksimetil-l* 1-dimetilpirilidinio tozilato* Produktas valomas* tirpinant 96% etanolyje ir apdorojant jonitu (ambėrlitu MB 3). . ·Incoming / under 7; The procedure described in Example 5 was prepared from 10/3 g / (38 mmol) octadecanol * 3.9 ml / (42 / Bimol) ^ phosphorus oxychloride, 13 + 16 ml pyridine and 15.1 g (50 mmol) 2-. h.hydroxymethyl-1 * 1-dimethylpyrillide tosylate * The product is purified * by dissolution in 96% ethanol and treatment with ion exchanger (Amberlite MB 3). . ·
Eleuentinė analizė: C HEleuent analysis: C H
Išskaičiuota: 63,80% 11,35% / Rasta: 63,13% 11,57%Calculated: 63.80% 11.35% / Found: 63.13% 11.57%
63,55% 11,66%63.55% 11.66%
NN
2,98% · 2,84% . 2, 82%2.98% · 2.84%. 2, 82%
Plonasluoksnė chromatograma:Thin layer chromatogram:
(chloroformas/metanolis/lM natrio -acetatas(chloroform / methanol / 1M sodium acetate)
25% amoniake 7©:40:10125% ammonia 7 ©: 40: 101
- Rj . — 0, 35 ' - . .. . .· . ,·- Rj. - 0, 35 '-. ... . ·. , ·
- Re ksadeci1-(1-met ilchinuklidinio-3-11)fos fatas- Re xadeci 1- (1-Methyl Ilchinuclidine-3-11) Phosphate
- '/'.-..-, 'n ,- '/'.-..-,' n,
72, 7 ml <30 mmol) fosforo oksichlorido ištirpinama 25 ml ./:7 chloroformo; I atšaldoma : iki7 5-10¾ /terojjėrątūros/ ir per ////vienąivalandą//sulašinamas' tirpalas/'Iš/6, 4/g-. <26 mmol) ; : : heksadėkanolio? ir ml piridino 50-je ml dhloroformo.72, 7 ml <30 mmol) of phosphorus oxychloride is dissolved in 25 ml ./7 of chloroform; I cool : to 7 5-10¾ / titer / and // // one hour // drip 'solution /' From / 6,4 / g-. <26 mmol); :: Hexadecanol ? and ml of pyridine in 50 ml of dichloroform.
Maišoma pusę valandos /kambario temperatūroje,- pridedama/Stir for half an hour / at room temperature - add /
-7/4,:5. ,:g//{35 /mmol)//-3^bidroksichinuklidino'/.ir-.-.5. ml piridino-7/4,: 5. ,: g // {35 /mmol)//-3^bydroxyquinuclidino'/.ir-.-.5. ml of pyridine
-'/. 10-je/ ml : chloroformo/· Mišinys maišomas 5 vai / /kambario /temperatūro je ir - hidrolizuojamas 15 / ml/vaiidens:, maišant dar pusę valandos .Po to plaunama -du kartus po 100 ml vandens/metanolio <1:1) mišiniu: Organinis sluoksnis džiovinamas /magnio sulfatu ir sausai nugarinamas. Liekana chromatografuojama per silikagelį, eliuentu naudojant metiieno chlorido/metanolio 80:25 ir metiieno- '/. In 10 / ml: chloroform / · The mixture is stirred at 5 rpm / room / temperature and - hydrolysed at 15 / ml / runner: with stirring for another half hour. It is then washed twice with 100 ml water / methanol <1: 1 ) mixture: The organic layer is dried / magnesium sulfate and evaporated to dryness. The residue is chromatographed on silica gel, eluting with 80:25 methylene chloride / methanol and methylene chloride.
...,//. chlorido/metano]io/25% /amoniako 80:25:5 mišinius/ Produktą turinčios frakcijos supilamos kartu, sausai nugarinama ir produktas kristalinamas' iš acetono...., //. chloride / methane] 25/25% / ammonia 80: 25: 5 / The product-containing fractions are combined, evaporated to dryness and the product crystallized from acetone.
Džiovinama vakuume virš P2O5/Vacuum drying over P 2 O 5 /
··
Išeiga: 4*95 g (44%) heksadecil- (chinuklidinio-3 ii) fosfato, i, '7-/'- 'c Yield: 4 * 95 g (44%) of hexadecyl- (quinuclidine-3 ii) phosphate, i, '7 - /' - ' c
4,95 g (11,5 -mmol) heksadecil*(chinuklidinio-35 - >1)fosfato ištirpinama 30-j e ml metanolio, turinčioDissolve 4.95 g (11.5 mmol) of hexadecyl * (quinuclide-35 → 1) phosphate in 30 ml of methanol containing
13,7 g (69 mmol) kalio karbonato ir 8,5 ml Vandens#. ir /.intensyviai;/'.-maišant, sumaišoma su 3,3 ml (35 mmol) dimetilsulfato -// tirpalu /5 ml metano lio. Ma i šoma 14 valandų- ^/--./ikaKberio.-.-///-,-/fcėa^eraturoje,//:/../)..-,nėfiltruojamos13.7 g (69 mmol) of potassium carbonate and 8.5 ml of Water #. and / or vigorously mixed with 3.3 ml (35 mmol) of dimethyl sulphate solution / 5 ml of methanol. Ma is rented for 14 hours- ^ / -. / IkaKberio.-.- /// -, - / fcéa ^ eratur, //: /../) ..-, not filtered
10. /neorganinės’ druskos,/;.//©^ sausai išgarinamas.10. / inorganic salts, / / / dry evaporated.
Liekana-^-tirpinama./ / •imetįįeBė//):čbloride*./i/$iltruo'j:aaaa - / ir 7 chromatografuejama per silikagelį/ eliuentu naudojant . metileno..:.-....)///cdiMri'do/metanclįc/25%///-^amoniako-)////70 :30-: 5 '-...'/mišinį:.'..// ; 7 7^ - ...7/ ' ' Produktą-'· - turinčios/ /frakcijos /supilamos// kartu, sausai išgarinama ./ir produktas ' ^.kristalinamas-// iš:.. acetono. Dži'oviiiama:/vakuume./virš/.P^05./' · . * ' ? '- ..7The residue - ^ - is solubilized.// • imbibition //) : chloride *. / I / $ iltruo'j: aaaa - / and 7 is chromatographed on silica gel / eluent. methylene ..:.-....) /// cdiMri'do / methanclc / 25% /// - ^ ammonia -) //// 70: 30-: 5 '-...' / mixture:. '..// ; 7 7 ^ - ... 7 / '' Product- '· - Containing // Fractions / Flasks // together, dry evaporated ./and product' ^ .crystallized - // from: .. acetone. J'oviiiama: / vacuum./op//.P^0 5 ./ '·. * ' ? '- ..7
Išeiga::-·/ž,'7/g'.. 149%) .. /:.7 ''/'.' /-'Elementinė-./analizė;.// ./-- . C H H <-.Išskai-čiuota:,/ .---.60,9^--/-7-.-.-^-^1.0-,.^8% .---.-.--)2,96% ' .. ) .Rasta: . .).61,.36%. /.-;-./11,04%- < .3,29%-61,:46% -.- ./11,22%7-)' 7' 3,29%Yield :: - · / z, '7 / g' .. 149%) .. /:.7 '' / '.'/-'Elementary-./analysis;.// ./--. CHH <-. Excluded:, / .---. 60.9 ^ - / - 7 -.-.- ^ - ^ 1.0 -,. ^ 8%. ---.-.--) 2 , 96% '..). Found :. .), 61, .36%. /.- ; -./11,04%- <.3,29 -61%, 46% ./11,22%7- -.-) '7' 3.29%
Plonas! uoksnėchromatogr ama;Thin! Layer Chromatography;
(chloroformas/metanolis/25% amoniakas .25. . . ' - 70:40:10) ' ' . ·/ . W “ 0 , 4 4(chloroform / methanol / 25% ammonia .25... '- 70:40:10)' '. · /. W "0, 4 4
2l7pavy2dys72l7pavy2dys7
Oktadėcil- (1 -meti! chinukl idlnio- 3 - ii) fosfatasOctadecyl- (1-methylquinucl idlnio-3 - ii) phosphate
C2eH52NO4P (473, 68) .2 H20C 2e H 52 NO 4 P (473, 68) .2 H 2 0
- ' 27- '27
Gaunamas pagal 5 pavyzdyje aprašytą metodiką iš 18,2 g (67,5 ' mmol) oktadekanolio, 7,0 ml (75 mmol) '.fosforo oksichlorido, 18 - 20 ml piridino ir 28,3 g (90 mmoljObtained according to the procedure described in Example 5 from 18.2 g (67.5 'mmol) octadecanol, 7.0 ml (75 mmol)'. Phosphorus oxychloride, 18-20 ml pyridine and 28.3 g (90 mmol).
3-hidrdksi-l-metilchinuklidinio tozilato. Produktas valomas,, tirpinant 96% etanolyje ir apdorojant jonitu (amberlitu ffl 3).3-Hydroxy-1-methylquinuclide tosylate. The product is purified by dissolution in 96% ethanol and treatment with ion exchanger (amberlite ffl 3).
Išeiga: 18,4 g (57%)Yield: 18.4 g (57%)
Elementinė analizė: C H N ' Išskaičiuota: 61,27% .... 11,07% 2,75%Elemental Analysis: C H N 'Calculated: 61.27% .... 11.07% 2.75%
Rasta: 61,27% 10,91% 2,45%' ' / 61,95% 11,23% . 2,51%Found: 61.27% 10.91% 2.45% '/ 61.95% 11.23%. 2.51%
Plonasluoksnė chromatograma:Thin layer chromatogram:
{.chloroformas/metanolis/1M natrio acetatas. 25% amoniake 70:40:10){.chloroform / methanol / 1M sodium acetate. 25% ammonia 70:40:10)
Rf = 0,37 . 1 .. '+ .- . ..: (l-butanolis/'iitb'rūgštis./vanduo' AOflOilO) . ...R f = 0.37. 1 .. '+ .-. .. : (l-butanol / 'iitb' acid. / water 'AOflOilO). ...
. . . Rf .= 0,13 ' ' ° 24-pavyzdys·. . . R f . = 0.13 '' ° 24-Example ·
Heksadecil- (1,1-di|iff iitropanio-4-lI) fosfatas </ Λ . Gaunamas pagal 5 pavyzdyje aprašytą metodiką iš 12,1 g 25 (50 mmol) heksadekanolio/ 5,1 ml (55 mmol) fosforo oksichlorido, 17 + 40 ml piridino ir 21,3 g (65 mmol)Hexadecyl- (1,1-di | iffititropanio-4-lI) phosphate </ Λ. Obtained according to the procedure of Example 5 from 12.1 g of 25 (50 mmol) hexadecanol / 5.1 ml (55 mmol) of phosphorus oxychloride, 17 + 40 ml of pyridine and 21.3 g (65 mmol).
4-hįdroksi-l,1-dimetiltropąnįo tozilato. Produktas valomas, tirpinant 96% etanolyje ir apdorojant jonitu {amberlitu MB 3). Perkristalinama iš acetono.4-hydroxy-1,1-dimethyltropicane tosylate. The product is purified by dissolving in 96% ethanol and treating with ion exchanger (amberlite MB 3). Recrystallization from acetone.
R ' ... , “ .'.R '...,'. '.
Išeiga: 11,3 g (49%)Yield: 11.3 g (49%)
RElementinė analizė: C K NRe-analysis: C K N
Išskaičiuota: 62,86% 10,97% 2,93¾Calculated: 62.86% 10.97% 2.93¾
LT3113.BLT3113.B
Rasta: 62,45% 11,52% 2,82%Found: 62.45% 11.52% 2.82%
62,58% 11,52% 2,75%62.58% 11.52% 2.75%
Plonasluoksnėchromątograma:Thin-layer chromogram:
(chioroformas/metanolis/lM natrio acetatas 5 25% amoniake 70:40:10}(chioroform / methanol / 1M sodium acetate 5 25% ammonia 70:40:10}
Z//;'.,/'. Rf = 0,28 77/-7725 pavyzdysZ //;'.,/ '. Rf = 0.28 77 / -7725 Example
Oktadecil- (1,1-άίιΚ6ΐί1ΐΓοραηίο-4-11} fosfatasOctadecyl- (1,1-άίιΚ6ΐί1ΐΓοραηίο-4-11} Phosphate
C27H54NO4P (487,708)C 27 H 54 NO 4 P (487,708)
Gaunamas pagal 5 pavyzdyje(aprašytą metodiką iš 13,5g 15 (50 mmol) oktadėkanolįo, 5,1 ml (55 mmol) fosforo oksichlorido, 17 + 20 ml piridino ir 21,3 g (65 mmol)Obtained according to the procedure described in Example 5 (13.5 g of 15 (50 mmol) octadecanol, 5.1 ml (55 mmol) of phosphorus oxychloride, 17 + 20 ml of pyridine and 21.3 g (65 mmol)).
4-hidroksi-l,1-dimetiltropanio tozilato. .. Produktas valomas, tirpinant 96% etanolyje ir apdorojant jonitu (amberlitu MB 3)»4-hydroxy-1,1-dimethyltropanyl tosylate. .. The product is purified by dissolving in 96% ethanol and treatment with ion exchanger (amberlite MB 3) »
7/;7 /;
Išeiga: 10,7 g (44%)Yield: 10.7 g (44%)
Plonasluoksnė chromatogr ama:Thin layer chromatography:
(chloroformas/metanolis/lM natrio acetatas ~25% amoniake 70:40;10) . Rf = 0,22 .(chloroform / methanol / 1M sodium acetate ~ 25% in ammonia 70:40; 10). R f = 0.22.
Claims (17)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4222910A DE4222910A1 (en) | 1992-07-11 | 1992-07-11 | New phospholipid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
LTIP620A LTIP620A (en) | 1994-07-15 |
LT3113B true LT3113B (en) | 1994-12-27 |
Family
ID=6463031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTIP620A LT3113B (en) | 1992-07-11 | 1993-06-04 | Novel phospholipide derivatives |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0579939B1 (en) |
JP (1) | JP3311431B2 (en) |
KR (1) | KR100297180B1 (en) |
CN (1) | CN1039012C (en) |
AT (1) | ATE176477T1 (en) |
AU (1) | AU664101B2 (en) |
BR (1) | BR9302809A (en) |
CA (2) | CA2100228C (en) |
CZ (1) | CZ290863B6 (en) |
DE (2) | DE4222910A1 (en) |
DK (1) | DK0579939T3 (en) |
EE (1) | EE03140B1 (en) |
ES (1) | ES2129053T3 (en) |
FI (1) | FI111262B (en) |
GR (1) | GR3029602T3 (en) |
HR (1) | HRP931046B1 (en) |
HU (1) | HU218783B (en) |
IL (1) | IL106289A (en) |
LT (1) | LT3113B (en) |
LV (1) | LV10870B (en) |
MX (1) | MX9304133A (en) |
NO (1) | NO306468B1 (en) |
PL (3) | PL175607B1 (en) |
RU (1) | RU2108336C1 (en) |
SG (1) | SG46249A1 (en) |
SI (1) | SI9300365B (en) |
SK (1) | SK283827B6 (en) |
TW (1) | TW304956B (en) |
UA (1) | UA40567C2 (en) |
YU (1) | YU49079B (en) |
ZA (1) | ZA934971B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007008810A (en) | 2005-01-21 | 2007-11-21 | Astex Therapeutics Ltd | Pharmaceutical compounds. |
UY30042A1 (en) | 2005-12-19 | 2007-07-31 | Zentaris Gmbh | NEW DERIVATIVES OF ALQUILFOSFOLÍPIDOS WITH REDUCED CYTOTOXICITY AND USES OF THE SAME. |
EP1800684A1 (en) * | 2005-12-20 | 2007-06-27 | Zentaris GmbH | Novel alkyl phospholipid derivatives and uses thereof |
EP1869981A1 (en) * | 2006-06-21 | 2007-12-26 | Staatliches Weinbauinstitut Freiburg | Alkylphospholipids and lysophospholipids for controlling plant pathogens |
JP5528807B2 (en) | 2006-10-12 | 2014-06-25 | アステックス、セラピューティックス、リミテッド | Compound drug |
WO2008044041A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0108565A2 (en) | 1982-11-08 | 1984-05-16 | Takeda Chemical Industries, Ltd. | Phospholipids, their production and use thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444766A (en) * | 1980-10-21 | 1984-04-24 | Boehringer Mannheim Gmbh | Sulfur-containing phospholipid compounds and therapeutic compositions |
DE3530767A1 (en) * | 1985-08-28 | 1987-03-12 | Max Planck Gesellschaft | AGENT AGAINST MULTIPLE Sclerosis |
CA1280369C (en) * | 1985-12-04 | 1991-02-19 | Hansjorg Eibl | Pharmaceutical with anti-tumor effect |
ES2036210T3 (en) * | 1986-07-14 | 1993-05-16 | Nippon Chemiphar Co., Ltd. | A PROCEDURE FOR THE PREPARATION OF A GLYCEROL DERIVATIVE. |
EP0284395B1 (en) * | 1987-03-24 | 1993-06-23 | Nippon Chemiphar Co., Ltd. | Novel glycerol derivative and anti-hypertensive agent |
DE3906952A1 (en) * | 1989-03-04 | 1990-09-06 | Boehringer Mannheim Gmbh | (3- (C (DOWN ARROW)) (DOWN ARROW) (DOWN ARROW) 6 (DOWN ARROW) -C (DOWN ARROW) 1 (DOWN ARROW) (DOWN ARROW) 8 (DOWN ARROW)) ALKANSULFINYL AND 2 SULPHONE -METHOXYMETHYL-PROPYL) - (2-TRIMETHYLAMMONIO-ETHYL) PHOSPHATES, METHOD FOR PRODUCING THE MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
DE3942933A1 (en) * | 1989-12-23 | 1991-06-27 | Boehringer Mannheim Gmbh | USE OF ALKYLPHOSPHOLIPIDES AS ANTIVIRAL MEDICINAL PRODUCTS AND NEW PHOSPHOLIPID DERIVATIVES |
DE4114586A1 (en) * | 1991-05-04 | 1992-11-05 | Boehringer Mannheim Gmbh | MEDICINAL PRODUCTS CONTAINING AZACYCLODIPHOSPHONIC ACID DERIVATIVES, NEW AZACYCLODIPHOSPHONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
-
1992
- 1992-07-11 DE DE4222910A patent/DE4222910A1/en not_active Ceased
-
1993
- 1993-06-01 TW TW082104345A patent/TW304956B/zh not_active IP Right Cessation
- 1993-06-03 DE DE59309355T patent/DE59309355D1/en not_active Expired - Lifetime
- 1993-06-03 SG SG1996001626A patent/SG46249A1/en unknown
- 1993-06-03 EP EP93108904A patent/EP0579939B1/en not_active Expired - Lifetime
- 1993-06-03 AT AT93108904T patent/ATE176477T1/en active
- 1993-06-03 ES ES93108904T patent/ES2129053T3/en not_active Expired - Lifetime
- 1993-06-03 DK DK93108904T patent/DK0579939T3/en active
- 1993-06-04 LT LTIP620A patent/LT3113B/en not_active IP Right Cessation
- 1993-06-23 CZ CZ19931249A patent/CZ290863B6/en not_active IP Right Cessation
- 1993-06-28 SK SK670-93A patent/SK283827B6/en not_active IP Right Cessation
- 1993-07-06 YU YU47393A patent/YU49079B/en unknown
- 1993-07-08 NO NO932502A patent/NO306468B1/en not_active IP Right Cessation
- 1993-07-08 PL PL93318680A patent/PL175607B1/en unknown
- 1993-07-08 JP JP16911493A patent/JP3311431B2/en not_active Expired - Lifetime
- 1993-07-08 PL PL93299624A patent/PL173388B1/en unknown
- 1993-07-08 PL PL93318679A patent/PL177811B1/en unknown
- 1993-07-09 FI FI933165A patent/FI111262B/en not_active IP Right Cessation
- 1993-07-09 AU AU41864/93A patent/AU664101B2/en not_active Expired
- 1993-07-09 MX MX9304133A patent/MX9304133A/en active IP Right Grant
- 1993-07-09 IL IL10628993A patent/IL106289A/en not_active IP Right Cessation
- 1993-07-09 HU HU9301992A patent/HU218783B/en unknown
- 1993-07-09 CA CA002100228A patent/CA2100228C/en not_active Expired - Lifetime
- 1993-07-09 UA UA93002052A patent/UA40567C2/en unknown
- 1993-07-09 HR HR931046A patent/HRP931046B1/en not_active IP Right Cessation
- 1993-07-09 BR BR9302809A patent/BR9302809A/en not_active Application Discontinuation
- 1993-07-09 RU RU93047049A patent/RU2108336C1/en active
- 1993-07-09 ZA ZA934971A patent/ZA934971B/en unknown
- 1993-07-09 SI SI9300365A patent/SI9300365B/en unknown
- 1993-07-09 CA CA002511753A patent/CA2511753C/en not_active Expired - Lifetime
- 1993-07-10 KR KR1019930012980A patent/KR100297180B1/en not_active IP Right Cessation
- 1993-07-10 CN CN93108564A patent/CN1039012C/en not_active Expired - Lifetime
- 1993-07-12 LV LVP-93-988A patent/LV10870B/en unknown
-
1994
- 1994-10-25 EE EE9400199A patent/EE03140B1/en unknown
-
1999
- 1999-03-08 GR GR990400689T patent/GR3029602T3/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0108565A2 (en) | 1982-11-08 | 1984-05-16 | Takeda Chemical Industries, Ltd. | Phospholipids, their production and use thereof |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102405220B (en) | Thiazole derivatives and their use as p2y12 receptor antagonists | |
SU1087052A3 (en) | X-ray contrast device | |
US4666895A (en) | Diphosphonic acid derivatives | |
ZA200300168B (en) | 3'-Prodrugs of 2'-deoxy-beta-L-nucleosides. | |
DK167808B1 (en) | Methylenebisphosphonic acid derivative, process for preparing it, and pharmaceutical composition which comprises these derivatives | |
LT3113B (en) | Novel phospholipide derivatives | |
US20110212923A1 (en) | Phosphate Derivatives of Substituted Benzoxazoles | |
US5155099A (en) | Alkylphosphonoserines and pharmaceutical compositions useful as cytostatic agents | |
EP0934949A1 (en) | 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives | |
US5405994A (en) | Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present | |
US6172050B1 (en) | Phospholipid derivatives | |
RU2247125C2 (en) | Conjugates of 4-benzylaminoquinolines with bile acid and their heteroanalogs, method for their preparing and drugs based on these compounds | |
JP3176720B2 (en) | Method for producing and purifying drug having anti-neoplastic activity, octadecyl- [2- (N-methylpiperidino) -ethyl] -phosphate, and method for preparing drug | |
JPS5929647A (en) | Manufacture of low alkyl ester of n-l-alpha- aspartyl-l-phenylalanine and intermediate | |
EP1385858B1 (en) | Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof | |
RU2126413C1 (en) | Phospholipid derivatives, a method of their synthesis, a pharmaceutical composition based on said, methods of a pharmaceutical composition preparing | |
US4609650A (en) | Double ester of 16β-ethylestran-17β-ol derivatives | |
DK149026B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF ADENINNUCLEOSIDE DERIVATIVES | |
EP0121635A1 (en) | 3',5',-Diarabinosides, their preparation and their therapeutical application | |
JPH0248588A (en) | Phosphoric mitemysin derivative | |
CA2159776C (en) | Imidobisphosphoric acids, process for their preparation, and use thereof | |
CA2085520C (en) | Stable hexahydrate of etoposide 4'-phosphate disodium salt | |
US20050010054A1 (en) | Preparation of crystalline polymorphs of fosinopril sodium | |
Kuszmann et al. | Synthesis of new sugar derivatives having potential antitumour activity: Part IX. Cyclic phosphoric acid derivatives | |
HU211672A9 (en) | Crystalline etoposide 4'-phosphate diethanolate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC9A | Transfer of patents |
Free format text: 20020306 * ZENTARIS AG,DE |
|
PD9A | Change of patent owner |
Owner name: ZENTARIS GMBH, DE Effective date: 20050222 |
|
PD9A | Change of patent owner |
Owner name: ZENTARIS GMBH, DE Effective date: 20060605 |
|
TC9A | Change of representative |
Owner name: ZENTARIS GMBH, DE |
|
MK9A | Expiry of a patent |
Effective date: 20130604 |